NPPA Fixes Ceiling Price Of 866 Formulations; Details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the ceiling price of 866 scheduled formulations.
This came In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date specified in column no. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of goods and services tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
1 | 5-aminosalicylic Acid | Suppository 500 mg Retention Enema | 1 Suppository | 16.95 | 1213(E) | 25.03.2020 |
2 | 5-aminosalicylic Acid | Tablet 400 mg | 1 Tablet | 7.49 | 1213(E) | 25.03.2020 |
3 | 5-Fluorouracil | Injection 250 mg/5 ml | 1 ml | 2.34 | 1213(E) | 25.03.2020 |
4 | 6-Mercaptopurine | Tablet 50mg | 1 Tablet | 6.47 | 1213(E) | 25.03.2020 |
5 | Abacavir | Tablet 300 mg | 1 Tablet | 47.27 | 1213(E) | 25.03.2020 |
6 | Abacavir (A) + Lamivudine (B) | Tablet 60 mg(A) + 30 mg(B) | 1 Tablet | 20.13 | 1213(E) | 25.03.2020 |
7 | Abacavir (A) + Lamivudine (B) | Tablet 600 mg(A)+ 300 mg(B) | 1 Tablet | 91.35 | 1213(E) | 25.03.2020 |
8 | Acetazolamide | Capsule 250 mg | 1 Capsule | 4.53 | 1213(E) | 25.03.2020 |
9 | Acetazolamide | Tablet 250 mg | 1 Tablet | 3.67 | 1213(E) | 25.03.2020 |
10 | Acetylsalicylic acid | Effervescent/ Dispersible/ Enteric coated Tablet 100 mg | 1 Tablet | 0.18 | 1213(E) | 25.03.2020 |
11 | Acetylsalicylic acid | Effervescent/ Dispersible/ Enteric coated Tablet 150 mg | 1 Tablet | 1.21 | 1213(E) | 25.03.2020 |
12 | Acetylsalicylic acid | Effervescent/ Dispersible/ | 1 Tablet | 1.23 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
Enteric coated Tablet 75 mg | ||||||
13 | Acetylsalicylic acid | Tablet 100 mg | 1 Tablet | 0.17 | 1213(E) | 25.03.2020 |
14 | Acetylsalicylic acid | Tablet 150 mg | 1 Tablet | 0.41 | 1213(E) | 25.03.2020 |
15 | Acetylsalicylic acid | Tablet 325mg | 1 Tablet | 0.55 | 1213(E) | 25.03.2020 |
16 | Acetylsalicylic acid | Tablet 350mg | 1 Tablet | 0.31 | 1213(E) | 25.03.2020 |
17 | Acetylsalicylic acid | Tablet 75 mg | 1 Tablet | 0.31 | 1213(E) | 25.03.2020 |
18 | Actinomycin D | Powder for Injection 0.5mg | Each Pack | 317.90 | 1213(E) | 25.03.2020 |
19 | Acyclovir | Ointment 3% | 1 gm | 10.44 | 1213(E) | 25.03.2020 |
20 | Acyclovir | Oral Liquid 400 mg/5ml | 1 ml | 1.27 | 1213(E) | 25.03.2020 |
21 | Acyclovir | Tablet 200 mg | 1 Tablet | 6.79 | 1213(E) | 25.03.2020 |
22 | Acyclovir | Tablet 400 mg | 1 Tablet | 12.34 | 1213(E) | 25.03.2020 |
23 | Acyclovir | Powder for Injection 250 mg | Each Pack | 356.17 | 1213(E) | 25.03.2020 |
24 | Acyclovir | Powder for Injection 500 mg | Each Pack | 460.03 | 1213(E) | 25.03.2020 |
25 | Adenosine | Injection 3mg/ml | 1 ml | 98.70 | 1213(E) | 25.03.2020 |
26 | Adrenaline | Injection 1 mg/ml | 1 ml | 15.69 | 1213(E) | 25.03.2020 |
27 | Albendazole | Oral Liquid 200 mg/5ml | 1 ml | 1.60 | 1213(E) | 25.03.2020 |
28 | Albendazole | Tablet 400 mg | 1 Tablet | 7.72 | 1213(E) | 25.03.2020 |
29 | Allopurinol | Tablet 100 mg | 1 Tablet | 1.91 | 1213(E) | 25.03.2020 |
30 | Allopurinol | Tablet 300 mg | 1 Tablet | 7.50 | 1213(E) | 25.03.2020 |
31 | All-trans Retinoic Acid | Capsule 10 mg | 1 Capsule | 82.00 | 1213(E) | 25.03.2020 |
32 | Alprostadil | Injection 0.5 mg/ml | 1 ml | 5676.93 | 1213(E) | 25.03.2020 |
33 | Alteplase | Powder for Injection 20 mg | Each Pack | 19040.03 | 1213(E) | 25.03.2020 |
34 | Alteplase | Powder for Injection 50 mg | Each Pack | 39753.72 | 1213(E) | 25.03.2020 |
35 | Amiodarone | Injection 50 mg/ml | 1 ml | 22.36 | 1213(E) | 25.03.2020 |
36 | Amiodarone | Tablet 100 mg | 1 Tablet | 5.73 | 1213(E) | 25.03.2020 |
37 | Amiodarone | Tablet 200 mg | 1 Tablet | 11.35 | 1213(E) | 25.03.2020 |
38 | Amitriptyline | Tablet 10 mg | 1 Tablet | 2.29 | 1213(E) | 25.03.2020 |
39 | Amitriptyline | Tablet 25 mg | 1 Tablet | 2.26 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
40 | Amitriptyline | Tablet 50 mg | 1 Tablet | 5.82 | 1213(E) | 25.03.2020 |
41 | Amitriptyline | Tablet 75 mg | 1 Tablet | 5.62 | 1213(E) | 25.03.2020 |
42 | Amlodipine | Tablet 10 mg | 1 Tablet | 5.08 | 1213(E) | 25.03.2020 |
43 | Amlodipine | Tablet 2.5 mg | 1 Tablet | 1.66 | 1213(E) | 25.03.2020 |
44 | Amlodipine | Tablet 5mg | 1 Tablet | 2.61 | 1213(E) | 25.03.2020 |
45 | Amoxicillin | Capsule 250 mg | 1 Capsule | 2.21 | 1213(E) | 25.03.2020 |
46 | Amoxicillin | Oral Liquid 250 mg/5ml | 1 ml | 1.35 | 1213(E) | 25.03.2020 |
47 | Amoxicillin | Capsule 500mg | 1 Capsule | 6.47 | 1213(E) | 25.03.2020 |
48 | Amoxicillin (A) + Clavulanic acid (B) | Dry Syrup 125 mg(A) + 31.25 (B)/5 ml | 1 ml | 2.17 | 1213(E) | 25.03.2020 |
49 | Amoxicillin (A) + Clavulanic acid (B) | Oral Liquid 200 mg(A) + 28.5 mg(B)/5ml | 1 ml | 1.81 | 1213(E) | 25.03.2020 |
50 | Amoxicillin (A) + Clavulanic acid (B) | Powder for Injection 500 mg(A) + 100 mg(B) | Each Pack | 90.24 | 1213(E) | 25.03.2020 |
51 | Amoxicillin (A) +Clavulanic acid (B) | Tablet 500mg(A) +125mg(B) | 1 Tablet | 18.01 | 1213(E) | 25.03.2020 |
52 | Amoxicillin (A) +Clavulanic acid (B) | Powder for Injection 1g (A) +200mg(B) | Each Pack | 125.89 | 1213(E) | 25.03.2020 |
53 | Amphotericin B (Lipid) | Powder for Injection 50 mg |
Each Pack | 3213.07 | 1213(E) | 25.03.2020 |
54 | Amphotericin B (Liposomal) | Powder for Injection 50 mg |
Each Pack | 7484.24 | 1213(E) | 25.03.2020 |
55 | Amphotericin B – Conventional | Powder for Injection 50 mg | Each Pack | 310.48 | 1213(E) | 25.03.2020 |
56 | Ampicillin | Powder for Injection 1 gm | Each Pack | 21.39 | 1213(E) | 25.03.2020 |
57 | Ampicillin | Powder for Injection 500 mg | Each Pack | 13.18 | 1213(E) | 25.03.2020 |
58 | Anti-D immunoglobulin | Injection 300mcg | Each Pack | 2139.67 | 1213(E) | 25.03.2020 |
59 | Anti-D Immunoglobulin | Injection 150mcg | Each Vial | 1667.80 | 1213(E) | 25.03.2020 |
60 | Anti-rabies immunoglobulin | Injection 150 IU/ml | 1 ml | 2781.05 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
61 | Anti-rabies immunoglobulin | Injection 300 IU/ml | 1 ml | 98.04 | 1213(E) | 25.03.2020 |
62 | Anti-tetanus immunoglobulin | 250IU | Each Pack | 1113.99 | 1213(E) | 25.03.2020 |
63 | Arsenic Trioxide | Injection 1mg/ml | 1 ml | 54.43 | 1213(E) | 25.03.2020 |
64 | Artemether (A) + Lumefantrine (B) | Oral Liquid 80 mg(A) +480 mg(B) /5ml | 1 ml | 4.04 | 1213(E) | 25.03.2020 |
65 | Artemether (A) + Lumefantrine (B) | Tablet 20 mg(A) + 120 mg(B) | 1 Tablet | 12.55 | 1213(E) | 25.03.2020 |
66 | Artemether (A) + Lumefantrine (B) | Tablet 40 mg(A) + 240 mg(B) | 1 Tablet | 16.18 | 1213(E) | 25.03.2020 |
67 | Artemether (A) + Lumefantrine (B) | Tablet 80 mg(A) + 480 mg(B) | 1 Tablet | 23.22 | 1213(E) | 25.03.2020 |
68 | Artesunate | Powder for Injection 120 mg | Each Pack | 417.13 | 1213(E) | 25.03.2020 |
69 | Artesunate | Powder for Injection 60 mg | Each Pack | 219.10 | 1213(E) | 25.03.2020 |
70 | Artesunate (A) + Sulphadoxine - Pyrimethamine (B) | Tablet 100 mg(A) + 1 Tablet (750 mg+ 37.5 mg) (B) | Combi pack | 29.57 | 1213(E) | 25.03.2020 |
71 | Artesunate (A) + Sulphadoxine - Pyrimethamine (B) | Tablet 150 mg(A) + 2 Tablet (500 mg+ 25 mg) (B) | Combi pack | 40.14 | 1213(E) | 25.03.2020 |
72 | Artesunate (A) + Sulphadoxine - Pyrimethamine (B) | Tablet 200 mg(A) + 2 Tablet (750 mg+ 37.5 mg) (B) | Combi pack | 36.60 | 1213(E) | 25.03.2020 |
73 | Artesunate (A) + Sulphadoxine - Pyrimethamine (B) | Tablet 25 mg(A) + 1 Tablet (250 mg+ 12.5 mg) (B) | Combi pack | 19.71 | 1213(E) | 25.03.2020 |
74 | Artesunate (A) + Sulphadoxine - Pyrimethamine (B) | 1 Tablet 50 mg(A) + 1 Tablet (500 mg+ 25 mg) (B) | Combi Pack | 21.27 | 1213(E) | 25.03.2020 |
75 | Ascorbic Acid (Vitamin C) | Tablet 100mg | 1 Tablet | 0.19 | 1213(E) | 25.03.2020 |
76 | Ascorbic Acid (Vitamin C) | Tablet 500 mg | 1 Tablet | 1.38 | 1213(E) | 25.03.2020 |
77 | Atazanavir (A) + Ritonavir (B) | Tablet 300 mg(A) + 100 mg(B) | 1 Tablet | 98.96 | 1213(E) | 25.03.2020 |
78 | Atenolol | Tablet 100 mg | 1 Tablet | 3.49 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
79 | Atenolol | Tablet 50 mg | 1 Tablet | 1.79 | 1213(E) | 25.03.2020 |
80 | Atorvastatin | Tablet 10 mg | 1 Tablet | 5.50 | 1213(E) | 25.03.2020 |
81 | Atorvastatin | Tablet 20 mg | 1 Tablet | 13.32 | 1213(E) | 25.03.2020 |
82 | Atorvastatin | Tablet 40 mg | 1 Tablet | 19.34 | 1213(E) | 25.03.2020 |
83 | Atracurium | Injection 10 mg/ml | Each Pack | 52.55 | 1213(E) | 25.03.2020 |
84 | Atropine | Ointment 1% | 1 gm | 3.79 | 1213(E) | 25.03.2020 |
85 | Atropine | Injection 0.6 mg/ml | 1 ml | 4.20 | 1213(E) | 25.03.2020 |
86 | Atropine | Drops 1% | 1 ml | 3.44 | 1213(E) | 25.03.2020 |
87 | Azathioprine | Tablet 50 mg | 1 Tablet | 10.17 | 1213(E) | 25.03.2020 |
88 | Azithromycin | Capsule 250 mg | 1 Capsule | 10.53 | 1213(E) | 25.03.2020 |
89 | Azithromycin | Capsule 500 mg | 1 Capsule | 16.62 | 1213(E) | 25.03.2020 |
90 | Azithromycin | Oral Liquid 200 mg/5ml | 1 ml | 3.09 | 1213(E) | 25.03.2020 |
91 | Azithromycin | Tablet 250mg | 1 Tablet | 10.58 | 1213(E) | 25.03.2020 |
92 | Azithromycin | Tablet 500mg | 1 Tablet | 21.34 | 1213(E) | 25.03.2020 |
93 | Azithromycin | Powder for Injection 500mg | Each Pack | 192.73 | 1213(E) | 25.03.2020 |
94 | Baclofen | Tablet 10 mg | 1 Tablet | 10.78 | 1213(E) | 25.03.2020 |
95 | Baclofen | Tablet 20 mg | 1 Tablet | 14.83 | 1213(E) | 25.03.2020 |
96 | Baclofen | Tablet 5 mg | 1 Tablet | 5.55 | 1213(E) | 25.03.2020 |
97 | BCG vaccine | Each Dose | 8.96 | 1213(E) | 25.03.2020 | |
98 | Benzathine benzylpenicillin | Powder for Injection 12 lac units | Each Pack | 18.28 | 1213(E) | 25.03.2020 |
99 | Benzathine benzylpenicillin | Powder for Injection 6 lac units | Each Pack | 12.09 | 1213(E) | 25.03.2020 |
100 | Benzoyl Peroxide | Cream 2.5% | 1 gm | 2.34 | 1213(E) | 25.03.2020 |
101 | Benzoyl Peroxide | Gel 2.5% | 1 gm | 3.76 | 1213(E) | 25.03.2020 |
102 | Benzyl penicillin | Powder for Injection 10 Lac Units | Each Pack | 7.82 | 1213(E) | 25.03.2020 |
103 | Betamethasone | Cream 0.05% | 1 gm | 0.58 | 1213(E) | 25.03.2020 |
104 | Betamethasone | Cream 0.1% | 1 gm | 0.84 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
105 | Betamethasone | Gel 0.05% | 1 gm | 0.53 | 1213(E) | 25.03.2020 |
106 | Betamethasone | Lotion 0.1% | 1 ml | 0.82 | 1213(E) | 25.03.2020 |
107 | Betamethasone | Lotion 0.5% | 1 ml | 0.53 | 1213(E) | 25.03.2020 |
108 | Betamethasone | Injection 4 mg/ml | 1 ml | 4.21 | 1213(E) | 25.03.2020 |
109 | Bicalutamide | Tablet 50 mg | 1 Tablet | 68.78 | 1213(E) | 25.03.2020 |
110 | Bisacodyl | Suppository 5 mg | 1 Suppository | 8.46 | 1213(E) | 25.03.2020 |
111 | Bisacodyl | Tablet 5 mg | 1 Tablet | 1.01 | 1213(E) | 25.03.2020 |
112 | Bleomycin | Powder for Injection 15 Units | Each Pack | 622.26 | 1213(E) | 25.03.2020 |
113 | Bortezomib | Powder for Injection 2 mg | Each Pack | 12328.88 | 1213(E) | 25.03.2020 |
114 | Budesonide | Nasal Spray 100 mcg/dose | 1 Dose | 0.91 | 1213(E) | 25.03.2020 |
115 | Budesonide | Nasal Spray 50 mcg/dose | 1 Dose | 1.02 | 1213(E) | 25.03.2020 |
116 | Budesonide | Respiratory Solution for use in Nebulizer 0.5 mg/ml | 1 ml | 10.74 | 1213(E) | 25.03.2020 |
117 | Budesonide | Respiratory Solution for use in Nebulizer 1 mg/ml | 1 ml | 12.95 | 1213(E) | 25.03.2020 |
118 | Budesonide | Inhalation (MDI) 100 mcg/dose | Per Metered Dose | 1.27 | 1213(E) | 25.03.2020 |
119 | Budesonide | Inhalation (MDI) 200 mcg/dose | Per metered Dose | 1.77 | 2292(E) | 10.07.2020 |
120 | Budesonide | Inhalation (DPI) 100 mcg/dose | Per Dose | 2.00 | 1213(E) | 25.03.2020 |
121 | Budesonide | Inhalation (DPI) 200 mcg/dose | Per Dose | 2.90 | 1213(E) | 25.03.2020 |
122 | Budesonide (A)+ Formoterol (B) | Inhalation (MDI) 100 mcg (A) + 6 mcg (B) | Per Metered Dose | 1.89 | 1213(E) | 25.03.2020 |
123 | Budesonide (A)+ Formoterol (B) | Inhalation (MDI) 200 mcg (A) + 6 mcg (B) | Per Metered Dose | 2.68 | 1213(E) | 25.03.2020 |
124 | Budesonide (A)+ Formoterol (B) | Inhalation (MDI) 400 mcg (A) + 6 mcg (B) | Per Metered Dose | 3.06 | 1213(E) | 25.03.2020 |
125 | Budesonide (A)+ Formoterol (B) | Inhalation (DPI) 100 mcg (A) + 6 mcg (B) | Per Dose | 3.80 | 1213(E) | 25.03.2020 |
126 | Budesonide (A)+ Formoterol (B) | Inhalation (DPI) 200 mcg (A) + 6 mcg (B) | Per Dose | 5.05 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
127 | Budesonide (A)+ Formoterol (B) | Inhalation (DPI) 400 mcg (A) + 6 mcg (B) | Per Dose | 6.45 | 1213(E) | 25.03.2020 |
128 | Bupivacaine | Injection 0.25% | 1 ml | 2.46 | 1213(E) | 25.03.2020 |
129 | Bupivacaine | Injection 0.5% with 7.5% glucose | 1 ml | 6.22 | 1213(E) | 25.03.2020 |
130 | Bupivacaine | Injection 0.50% | 1 ml | 3.93 | 1213(E) | 25.03.2020 |
131 | Caffeine | Injection 20 mg/ml | 1 ml | 251.61 | 1213(E) | 25.03.2020 |
132 | Caffeine | Oral Liquid 20 mg/ml | 1 ml | 213.70 | 1213(E) | 25.03.2020 |
133 | Calamine | Lotion (As per IP) | 1 ml | 0.85 | 1213(E) | 25.03.2020 |
134 | Calcium Carbonate | Tablet 500mg | 1 Tablet | 1.73 | 1213(E) | 25.03.2020 |
135 | Calcium folinate | Tablet 15 mg | 1 Tablet | 40.89 | 1213(E) | 25.03.2020 |
136 | Calcium gluconate | Injection 100 mg/ml | 1 ml | 0.55 | 1213(E) | 25.03.2020 |
137 | Capecitabine | Tablet 500 mg | 1 Tablet | 126.69 | 1213(E) | 25.03.2020 |
138 | Capreomycin | Powder for Injection 1 gm | Each Pack | 347.22 | 1213(E) | 25.03.2020 |
139 | Carbamazepine | Oral Liquid 100 mg/5ml | 1 ml | 0.19 | 1213(E) | 25.03.2020 |
140 | Carbamazepine | CR Tablet 200 mg | 1 Tablet | 1.56 | 1213(E) | 25.03.2020 |
141 | Carbamazepine | CR Tablet 400 mg | 1 Tablet | 3.07 | 1213(E) | 25.03.2020 |
142 | Carbamazepine | Tablet 100 mg | 1 Tablet | 0.68 | 1213(E) | 25.03.2020 |
143 | Carbamazepine | Tablet 200 mg | 1 Tablet | 1.40 | 1213(E) | 25.03.2020 |
144 | Carbamazepine | Tablet 400 mg | 1 Tablet | 3.31 | 1213(E) | 25.03.2020 |
145 | Carbimazole | Tablet 10 mg | 1 Tablet | 3.71 | 1213(E) | 25.03.2020 |
146 | Carbimazole | Tablet 5 mg | 1 Tablet | 1.91 | 1213(E) | 25.03.2020 |
147 | Carboplatin | Injection 10 mg/ml | 1 ml | 53.34 | 1213(E) | 25.03.2020 |
148 | Carboxymethylcell ulose | Drops 0.5% | 1 ml | 12.81 | 1213(E) | 25.03.2020 |
149 | Carboxymethylcell ulose | Drops 1% | 1 ml | 17.75 | 1213(E) | 25.03.2020 |
150 | Cefadroxil | Capsule 500 mg | 1 Capsule | 7.17 | 1213(E) | 25.03.2020 |
151 | Cefadroxil | Oral Liquid 125 mg/5ml | 1 ml | 0.63 | 1213(E) | 25.03.2020 |
152 | Cefadroxil | Tablet 1 gm | 1 Tablet | 6.30 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
153 | Cefadroxil | Tablet 500 mg | 1 Tablet | 4.04 | 1213(E) | 25.03.2020 |
154 | Cefazolin | Powder for Injection 1 gm | Each Pack | 24.61 | 1213(E) | 25.03.2020 |
155 | Cefazolin | Powder for Injection 500 mg | Each Pack | 15.60 | 1213(E) | 25.03.2020 |
156 | Cefixime | Capsule 200 mg | 1 Capsule | 14.47 | 1213(E) | 25.03.2020 |
157 | Cefixime | Capsule 400 mg | 1 Capsule | 29.31 | 1213(E) | 25.03.2020 |
158 | Cefixime | Oral Liquid 100 mg/5ml | 1 ml | 2.16 | 1213(E) | 25.03.2020 |
159 | Cefixime | Oral Liquid 50 mg/5ml | 1 ml | 1.46 | 1213(E) | 25.03.2020 |
160 | Cefixime | Tablet 400 mg | 1 Tablet | 22.12 | 1213(E) | 25.03.2020 |
161 | Cefixime | Tablet 200mg | 1 Tablet | 9.62 | 1213(E) | 25.03.2020 |
162 | Cefotaxime | Powder for Injection 1 gm | Each Pack | 34.40 | 1213(E) | 25.03.2020 |
163 | Cefotaxime | Powder for Injection 250 mg | Each Pack | 15.64 | 1213(E) | 25.03.2020 |
164 | Cefotaxime | Powder for Injection 500 mg | Each Pack | 20.57 | 1213(E) | 25.03.2020 |
165 | Ceftazidime | Powder for Injection 1 gm | Each Pack | 209.80 | 1213(E) | 25.03.2020 |
166 | Ceftazidime | Powder for Injection 250 mg | Each Pack | 65.25 | 1213(E) | 25.03.2020 |
167 | Ceftriaxone | Powder for Injection 1gm | Each Pack | 54.04 | 1213(E) | 25.03.2020 |
168 | Ceftriaxone | Powder for Injection 2 gm | Each Pack | 128.46 | 1213(E) | 25.03.2020 |
169 | Ceftriaxone | Powder for Injection 250 mg | Each Pack | 24.74 | 1213(E) | 25.03.2020 |
170 | Ceftriaxone | Powder for Injection 500 mg | Each Pack | 45.19 | 1213(E) | 25.03.2020 |
171 | Cetirizine | Capsule 10 mg | 1 Capsule | 2.38 | 1213(E) | 25.03.2020 |
172 | Cetirizine | Oral Liquid 5 mg/5ml | 1 ml | 0.59 | 1213(E) | 25.03.2020 |
173 | Cetirizine | Tablet 10 mg | 1 Tablet | 1.66 | 1213(E) | 25.03.2020 |
174 | Cetrimide | Solution 20% (concentrate for dilution) | 1 ml | 0.32 | 1213(E) | 25.03.2020 |
175 | Chlorambucil | Tablet 2 mg | 1 Tablet | 37.00 | 1213(E) | 25.03.2020 |
176 | Chlorambucil | Tablet 5 mg | 1 Tablet | 83.14 | 1213(E) | 25.03.2020 |
177 | Chlorhexidine | Solution 5% (Concentrate for dilution) | 1 ml | 0.15 | 1213(E) | 25.03.2020 |
178 | Chloroquine | Oral Liquid 50 mg/5ml | 1 ml | 0.30 | 1213(E) | 25.03.2020 |
179 | Chloroquine | Tablet 150mg | 1 Tablet | 1.19 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
180 | Chlorpheniramine | Tablet 4 mg | 1 Tablet | 0.09 | 1213(E) | 25.03.2020 |
181 | Cholecalciferol | Capsule 1000 IU | 1 Capsule | 4.79 | 1213(E) | 25.03.2020 |
182 | Cholecalciferol | Capsule 60000 IU | 1 Capsule | 29.60 | 1213(E) | 25.03.2020 |
183 | Cholecalciferol | Oral Liquid 400 IU/ml | 1 ml | 2.35 | 1213(E) | 25.03.2020 |
184 | Cholecalciferol | Tablet 1000 IU | 1 Tablet | 3.76 | 1213(E) | 25.03.2020 |
185 | Cholecalciferol | Tablet 60000 IU | 1 Tablet | 24.31 | 1213(E) | 25.03.2020 |
186 | Ciprofloxacin | Ointment 0.3% | 1 gm | 1.14 | 1213(E) | 25.03.2020 |
187 | Ciprofloxacin | Drops 0.30% | 1 ml | 1.53 | 1213(E) | 25.03.2020 |
188 | Ciprofloxacin | Injection 200 mg/100ml | 1 ml | 0.17 | 1213(E) | 25.03.2020 |
189 | Ciprofloxacin | Oral Liquid 250 mg/5ml | 1 ml | 0.63 | 1213(E) | 25.03.2020 |
190 | Ciprofloxacin | Tablet 250mg | 1 Tablet | 2.08 | 1213(E) | 25.03.2020 |
191 | Ciprofloxacin | Tablet 500mg | 1 Tablet | 3.66 | 1213(E) | 25.03.2020 |
192 | Cisplatin | Injection 1 mg/ml | 1 ml | 6.91 | 1213(E) | 25.03.2020 |
193 | Clarithromycin | Oral Liquid 125 mg/5ml | 1 ml | 4.32 | 1213(E) | 25.03.2020 |
194 | Clarithromycin | Tablet 250 mg | 1 Tablet | 28.07 | 1213(E) | 25.03.2020 |
195 | Clarithromycin | Tablet 500 mg | 1 Tablet | 49.47 | 1213(E) | 25.03.2020 |
196 | Clindamycin | Capsule 150 mg | 1 Capsule | 14.51 | 1213(E) | 25.03.2020 |
197 | Clindamycin | Capsule 300 mg | 1 Capsule | 23.69 | 1213(E) | 25.03.2020 |
198 | Clindamycin | Tablet 300 mg | 1 Tablet | 15.28 | 1213(E) | 25.03.2020 |
199 | Clobazam | Tablet 10 mg | 1 Tablet | 9.06 | 1213(E) | 25.03.2020 |
200 | Clobazam | Tablet 5 mg | 1 Tablet | 5.15 | 1213(E) | 25.03.2020 |
201 | Clofazimine | Capsule 100 mg | 1 Capsule | 3.72 | 1213(E) | 25.03.2020 |
202 | Clofazimine | Capsule 50 mg | 1 Capsule | 2.18 | 1213(E) | 25.03.2020 |
203 | Clomiphene | Capsule 100 mg | 1 Capsule | 55.80 | 1213(E) | 25.03.2020 |
204 | Clomiphene | Capsule 50 mg | 1 Capsule | 30.69 | 1213(E) | 25.03.2020 |
205 | Clomiphene | Tablet 100mg | 1 Tablet | 12.25 | 1213(E) | 25.03.2020 |
206 | Clomiphene | Tablet 50mg | 1 Tablet | 8.34 | 1213(E) | 25.03.2020 |
207 | Clomipramine | Tablet 10 mg | 1 Tablet | 2.52 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
208 | Clomipramine | Tablet 25 mg | 1 Tablet | 5.56 | 1213(E) | 25.03.2020 |
209 | Clomipramine | Tablet 75 mg | 1 Tablet | 14.38 | 1213(E) | 25.03.2020 |
210 | Clonazepam | Tablet 0.25 mg | 1 Tablet | 1.83 | 1213(E) | 25.03.2020 |
211 | Clonazepam | Tablet 0.5 mg | 1 Tablet | 3.12 | 1213(E) | 25.03.2020 |
212 | Clonazepam | Tablet 1 mg | 1 Tablet | 4.24 | 1213(E) | 25.03.2020 |
213 | Clopidogrel | Tablet 75 mg | 1 Tablet | 6.97 | 1213(E) | 25.03.2020 |
214 | Clotrimazole | Cream 1% | 1 gm | 2.92 | 1213(E) | 25.03.2020 |
215 | Clotrimazole | Drops 1% | 1 ml | 3.04 | 1213(E) | 25.03.2020 |
216 | Clotrimazole | Lotion 1% | 1 ml | 3.59 | 1213(E) | 25.03.2020 |
217 | Clotrimazole | Pessary 100 mg | 1 Pessary | 8.71 | 1213(E) | 25.03.2020 |
218 | Cloxacillin | Capsule 250mg | 1 Capsule | 1.14 | 1213(E) | 25.03.2020 |
219 | Cloxacillin | Capsule 500mg | 1 Capsule | 1.91 | 1213(E) | 25.03.2020 |
220 | Cloxacillin | Tablet 250mg | 1 Tablet | 1.73 | 1213(E) | 25.03.2020 |
221 | Cloxacillin | Powder for Injection250mg | Each Pack | 4.45 | 1213(E) | 25.03.2020 |
222 | Clozapine | Tablet 100 mg | 1 Tablet | 7.76 | 1213(E) | 25.03.2020 |
223 | Clozapine | Tablet 25 mg | 1 Tablet | 2.52 | 1213(E) | 25.03.2020 |
224 | Clozapine | Tablet 50 mg | 1 Tablet | 4.82 | 1213(E) | 25.03.2020 |
225 | Coagulation factor IX | Powder for Injection 600 IU | Each Pack | 12350.88 | 1213(E) | 25.03.2020 |
226 | Coagulation factor VIII | Powder for Injection 250 IU | Each pack | 3744.09 | 1213(E) | 25.03.2020 |
227 | Coagulation factor VIII | Powder for Injection 500 IU | Each Pack | 9187.72 | 1213(E) | 25.03.2020 |
228 | Colchicine | Tablet 0.5 mg | 1 Tablet | 3.12 | 1213(E) | 25.03.2020 |
229 | Co-trimoxazole (Sulphamethoxazol e (A)+Trimethoprim (B)] | Oral Liquid 200 mg(A)+40 mg(B)/5ml | 1 ml | 0.33 | 1213(E) | 25.03.2020 |
230 | Co-trimoxazole (Sulphamethoxazol e (A)+Trimethoprim | Tablet 400 mg(A)+80 mg(B) | 1 Tablet | 0.78 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
(B)] | ||||||
231 | Co-trimoxazole (Sulphamethoxazol e (A)+Trimethoprim (B)] | Tablet 800 mg(A)+160 mg(B) | 1 Tablet | 2.03 | 1213(E) | 25.03.2020 |
232 | Cyclophosphamide | Tablet 50 mg | 1 Tablet | 4.06 | 1213(E) | 25.03.2020 |
233 | Cyclophosphamide | Powder for Injection 500 mg | Each Pack | 80.01 | 1213(E) | 25.03.2020 |
234 | Cycloserine | Capsule 250 mg | 1 Capsule | 54.42 | 1213(E) | 25.03.2020 |
235 | Cycloserine | Tablet 250 mg | 1 Tablet | 46.79 | 1213(E) | 25.03.2020 |
236 | Cyclosporine | Capsule 100 mg | 1 Capsule | 102.75 | 1213(E) | 25.03.2020 |
237 | Cyclosporine | Capsule 25 mg | 1 Capsule | 27.58 | 1213(E) | 25.03.2020 |
238 | Cyclosporine | Capsule 50 mg | 1 Capsule | 52.77 | 1213(E) | 25.03.2020 |
239 | Cyclosporine | Injection 50 mg/ml | 1 ml | 270.37 | 1213(E) | 25.03.2020 |
240 | Cyclosporine | Oral Liquid 100 mg/ml | 1 ml | 94.75 | 1213(E) | 25.03.2020 |
241 | Cytosine arabinoside | Injection 100 mg/ml | Each Pack | 199.15 | 1213(E) | 25.03.2020 |
242 | Cytosine arabinoside | Powder for Injection 1000 mg | Each Pack | 1074.14 | 1213(E) | 25.03.2020 |
243 | Cytosine arabinoside | Powder for Injection 500 mg | Each Pack | 513.39 | 1213(E) | 25.03.2020 |
244 | Dacarbazine | Powder for Injection 200 mg | Each Pack | 440.38 | 1213(E) | 25.03.2020 |
245 | Dacarbazine | Powder for Injection 500 mg | Each Pack | 993.45 | 1213(E) | 25.03.2020 |
246 | Dapsone | Tablet 100 mg | 1 Tablet | 0.36 | 1213(E) | 25.03.2020 |
247 | Darunavir | Tablet 600 mg | 1 Tablet | 167.32 | 1213(E) | 25.03.2020 |
248 | Daunarubicin | Powder for I.V. Injection 20 mg (5 mg/ml) | Each pack | 243.77 | 1213(E) | 25.03.2020 |
249 | Desferrioxamine | Powder for Injection 500mg | Each pack | 161.20 | 1213(E) | 25.03.2020 |
250 | Dexamethasone | Tablet 0.5 mg | 1 Tablet | 0.19 | 1213(E) | 25.03.2020 |
251 | Dexamethasone | Injection 4 mg/ml | Each Pack (10 ml) | 13.80 | 1213(E) | 25.03.2020 |
252 | Dexamethasone | Injection 4 mg/ml | Each Pack (2 ml) | 9.34 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
253 | Dexamethasone | Injection 4 mg/ml | Each Pack (20 ml) | 26.46 | 1213(E) | 25.03.2020 |
254 | Dexamethasone | Injection 4 mg/ml | Each Pack (30 ml) | 35.36 | 1213(E) | 25.03.2020 |
255 | Dextran-40 | Injection 10% | 1 ml | 0.85 | 1213(E) | 25.03.2020 |
256 | Diazepam | Injection 5 mg/ml | 1 ml | 6.07 | 1213(E) | 25.03.2020 |
257 | Diazepam | Oral Liquid 2 mg/5ml | 1 ml | 2.74 | 1213(E) | 25.03.2020 |
258 | Diazepam | Suppository 5 mg | 1 Suppository | 5.99 | 1213(E) | 25.03.2020 |
259 | Diazepam | Tablet 2 mg | 1 Tablet | 1.51 | 1213(E) | 25.03.2020 |
260 | Diazepam | Tablet 5 mg | 1 Tablet | 1.43 | 1213(E) | 25.03.2020 |
261 | Diclofenac | Capsule 50 mg | 1 Capsule | 0.61 | 1213(E) | 25.03.2020 |
262 | Diclofenac | Injection 25 mg/ml | 1 ml | 1.47 | 1213(E) | 25.03.2020 |
263 | Diclofenac | Tablet 50 mg | 1 Tablet | 1.92 | 1213(E) | 25.03.2020 |
264 | Dicyclomine | Injection 10 mg/ml (10ml & 30ml Pack) | 1 ml | 2.06 | 1213(E) | 25.03.2020 |
265 | Dicyclomine | Injection 10 mg/ml (1ml & 2ml Pack) | 1 ml | 3.20 | 1213(E) | 25.03.2020 |
266 | Dicyclomine | Oral Solution 10mg/5ml | 1 ml | 0.16 | 1213(E) | 25.03.2020 |
267 | Dicyclomine | Tablet 10mg | 1 Tablet | 0.11 | 1213(E) | 25.03.2020 |
268 | Diethylcarbamazin e | Oral Liquid 120 mg/5ml | 1 ml | 0.49 | 1213(E) | 25.03.2020 |
269 | Diethylcarbamazin e | Tablet 100 mg | 1 Tablet | 1.42 | 1213(E) | 25.03.2020 |
270 | Diethylcarbamazin e | Tablet 50 mg | 1 Tablet | 0.56 | 1213(E) | 25.03.2020 |
271 | Digoxin | Injection 0.25 mg/ml | 1 ml | 3.34 | 1213(E) | 25.03.2020 |
272 | Digoxin | Oral liquid 0.05 mg/ml | 1 ml | 1.27 | 1213(E) | 25.03.2020 |
273 | Digoxin | Tablet 0.25 mg | 1 Tablet | 1.20 | 1213(E) | 25.03.2020 |
274 | Diloxanide furoate | Tablet 500mg | 1 Tablet | 1.06 | 1213(E) | 25.03.2020 |
275 | Diltiazem | Capsule 90 mg | 1 Capsule | 9.63 | 1213(E) | 25.03.2020 |
276 | Diltiazem | Injection 5 mg/ml | 1 ml | 3.17 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
277 | Diltiazem | SR Tablet 90 mg | 1 Tablet | 9.35 | 1213(E) | 25.03.2020 |
278 | Diltiazem | Tablet 30 mg | 1 Tablet | 2.40 | 1213(E) | 25.03.2020 |
279 | Diltiazem | Tablet 60 mg | 1 Tablet | 4.90 | 1213(E) | 25.03.2020 |
280 | Dimercaprol | Injection 50 mg/ml | 1 ml | 200.62 | 1213(E) | 25.03.2020 |
281 | Dinoprostone | Gel 0.5 mg | 1 gm | 81.26 | 1213(E) | 25.03.2020 |
282 | Dinoprostone | Tablet 0.5mg | 1 Tablet | 50.17 | 1213(E) | 25.03.2020 |
283 | Diphtheria antitoxin | 10000 IU | Each Pack | 1313.77 | 1213(E) | 25.03.2020 |
284 | Dobutamine | Injection 50 mg/ml | Each Pack | 37.59 | 1213(E) | 25.03.2020 |
285 | Docetaxel | Powder for Injection 20 mg | Each Pack | 3000.60 | 1213(E) | 25.03.2020 |
286 | Docetaxel | Powder for Injection 80 mg | Each Pack | 11408.49 | 1213(E) | 25.03.2020 |
287 | Domperidone | Oral Liquid 1 mg/ml | 1 ml | 1.08 | 1213(E) | 25.03.2020 |
288 | Domperidone | Tablet 10 mg | 1 Tablet | 2.42 | 1213(E) | 25.03.2020 |
289 | Donepezil | Tablet 10 mg | 1 Tablet | 16.09 | 1213(E) | 25.03.2020 |
290 | Donepezil | Tablet 5 mg | 1 Tablet | 11.27 | 1213(E) | 25.03.2020 |
291 | Dopamine | Injection 40 mg/ml | 1 ml | 5.66 | 1213(E) | 25.03.2020 |
292 | Doxorubicin | Injection 2 mg/ml | 1 ml | 35.99 | 1213(E) | 25.03.2020 |
293 | Doxycycline | Capsule 100 mg | 1 Capsule | 2.51 | 1213(E) | 25.03.2020 |
294 | Doxycycline | Tablet 100 mg | 1 Tablet | 0.98 | 1213(E) | 25.03.2020 |
295 | DPT + Hib + Hep B vaccine | Per 0.1 ml | 80.51 | 1213(E) | 25.03.2020 | |
296 | DPT vaccine | Per 0.5 ml | 14.20 | 1213(E) | 25.03.2020 | |
297 | Efavirenz | Capsule 200 mg | 1 Capsule | 24.13 | 1213(E) | 25.03.2020 |
298 | Efavirenz | Capsule 600 mg | 1 Capsule | 62.88 | 1213(E) | 25.03.2020 |
299 | Efavirenz | Tablet 200 mg | 1 Tablet | 22.73 | 1213(E) | 25.03.2020 |
300 | Efavirenz | Tablet 600 mg | 1 Tablet | 71.19 | 1213(E) | 25.03.2020 |
301 | Enalapril | Tablet 2.5 mg | 1 Tablet | 1.94 | 1213(E) | 25.03.2020 |
302 | Enalapril | Tablet 5 mg | 1 Tablet | 3.22 | 1213(E) | 25.03.2020 |
303 | Enoxaparin | Injection 40 mg/0.4ml | 0.1 ml | 101.89 | 1213(E) | 25.03.2020 |
304 | Enoxaparin | Injection 60 mg/0.6ml | 0.1 ml | 101.89 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
305 | Entecavir | Tablet 0.5 mg | 1 Tablet | 79.98 | 1213(E) | 25.03.2020 |
306 | Entecavir | Tablet 1 mg | 1 Tablet | 127.08 | 1213(E) | 25.03.2020 |
307 | Erythropoietin | Injection 10000 IU/ml | Each pack | 2607.78 | 1213(E) | 25.03.2020 |
308 | Erythropoietin | Injection 2000 IU/ml | Each pack | 617.66 | 1213(E) | 25.03.2020 |
309 | Escitalopram | Tablet 10 mg | 1 Tablet | 8.12 | 1213(E) | 25.03.2020 |
310 | Escitalopram | Tablet 20 mg | 1 Tablet | 12.83 | 1213(E) | 25.03.2020 |
311 | Escitalopram | Tablet 5 mg | 1 Tablet | 4.57 | 1213(E) | 25.03.2020 |
312 | Esmolol | Injection 10mg/ml | 1 ml | 21.72 | 1213(E) | 25.03.2020 |
313 | Ethambutol | Tablet 200 mg | 1 Tablet | 1.06 | 1213(E) | 25.03.2020 |
314 | Ethambutol | Tablet 400 mg | 1 Tablet | 2.40 | 1213(E) | 25.03.2020 |
315 | Ethambutol | Tablet 600 mg | 1 Tablet | 3.55 | 1213(E) | 25.03.2020 |
316 | Ethambutol | Tablet 800 mg | 1 Tablet | 4.24 | 1213(E) | 25.03.2020 |
317 | Ethinylestradiol | Tablet 0.01 mg | 1 Tablet | 2.35 | 1213(E) | 25.03.2020 |
318 | Ethinylestradiol | Tablet 0.05 mg | 1 Tablet | 3.76 | 1213(E) | 25.03.2020 |
319 | Ethinylestradiol (A) + Levonorgestrel (B) | Tablet 0.03 mg(A) + 0.15 mg(B) | 1 Tablet | 3.46 | 1213(E) | 25.03.2020 |
320 | Ethionamide | Tablet 250 mg | 1 Tablet | 15.82 | 1213(E) | 25.03.2020 |
321 | Ethyl Alcohol (Denatured) | Solution 70% | 1 ml | 0.42 | 1213(E) | 25.03.2020 |
322 | Etoposide | Capsule 50 mg | 1 Capsule | 54.50 | 1213(E) | 25.03.2020 |
323 | Etoposide | Injection 20 mg/ml | 1 ml | 35.94 | 1213(E) | 25.03.2020 |
324 | Fentanyl | Injection 50mcg/ml | 1 ml | 22.76 | 1213(E) | 25.03.2020 |
325 | Ferrous Salt (A) + Folic Acid (B) | Tablet 100mg elemental iron (A) + 500mcg (B) | 1 Tablet | 0.23 | 1213(E) | 25.03.2020 |
326 | Filgrastim | Injection 300 mcg | Each pack | 1375.63 | 1213(E) | 25.03.2020 |
327 | Fluconazole | Capsule 100 mg | 1 Capsule | 25.33 | 1213(E) | 25.03.2020 |
328 | Fluconazole | Capsule 150 mg | 1 Capsule | 18.59 | 1213(E) | 25.03.2020 |
329 | Fluconazole | Capsule 200 mg | 1 Capsule | 36.60 | 1213(E) | 25.03.2020 |
330 | Fluconazole | Oral Liquid 50mg/5ml | 1 ml | 2.62 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
331 | Fluconazole | Tablet 100 mg | 1 Tablet | 8.00 | 1213(E) | 25.03.2020 |
332 | Fluconazole | Tablet 150 mg | 1 Tablet | 11.87 | 1213(E) | 25.03.2020 |
333 | Fluconazole | Tablet 200 mg | 1 Tablet | 18.83 | 1213(E) | 25.03.2020 |
334 | Fluconazole | Tablet 400 mg | 1 Tablet | 31.32 | 1213(E) | 25.03.2020 |
335 | Fluconazole | Injection 200 mg/100 ml | Each Pack | 106.68 | 1213(E) | 25.03.2020 |
336 | Flunarizine | Tablet 10 mg | 1 Tablet | 4.75 | 1213(E) | 25.03.2020 |
337 | Flunarizine | Tablet 5 mg | 1 Tablet | 2.76 | 1213(E) | 25.03.2020 |
338 | Fluoxetine | Capsule 10 mg | 1 Capsule | 2.98 | 1213(E) | 25.03.2020 |
339 | Fluoxetine | Capsule 20 mg | 1 Capsule | 3.66 | 1213(E) | 25.03.2020 |
340 | Fluoxetine | Capsule 40 mg | 1 Capsule | 5.55 | 1213(E) | 25.03.2020 |
341 | Fluoxetine | Capsule 60 mg | 1 Capsule | 9.81 | 1213(E) | 25.03.2020 |
342 | Fluoxetine | Tablet 10 mg | 1 Tablet | 2.50 | 1213(E) | 25.03.2020 |
343 | Fluoxetine | Tablet 20 mg | 1 Tablet | 3.97 | 1213(E) | 25.03.2020 |
344 | Fluoxetine | Tablet 40 mg | 1 Tablet | 5.35 | 1213(E) | 25.03.2020 |
345 | Fluoxetine | Tablet 60 mg | 1 Tablet | 7.42 | 1213(E) | 25.03.2020 |
346 | Fluphenazine | Depot Injection 25 mg/ml | 1 ml | 50.15 | 1213(E) | 25.03.2020 |
347 | Folic Acid | Capsule 5 mg | 1 Capsule | 5.65 | 1213(E) | 25.03.2020 |
348 | Folic Acid | Tablet 5 mg | 1 Tablet | 1.40 | 1213(E) | 25.03.2020 |
349 | Furosemide | Oral liquid 10 mg/ml | 1 ml | 2.77 | 1213(E) | 25.03.2020 |
350 | Furosemide | Tablet 40 mg | 1 Tablet | 0.75 | 1213(E) | 25.03.2020 |
351 | Furosemide | Injection 10mg/ml | 1 ml | 2.49 | 1213(E) | 25.03.2020 |
352 | Fusidic acid | Cream 2% | 1 gm | 9.15 | 1213(E) | 25.03.2020 |
353 | Gadobenate | Injection 529 mg/ml | 1 ml | 109.25 | 1213(E) | 25.03.2020 |
354 | Ganciclovir | Capsule 250 mg | 1 Capsule | 120.51 | 1213(E) | 25.03.2020 |
355 | Ganciclovir | Powder for Injection 500 mg | Each Pack | 1691.68 | 1213(E) | 25.03.2020 |
356 | Gefitinib | Tablet 250 mg | 1 Tablet | 429.64 | 1213(E) | 25.03.2020 |
357 | Gemcitabine | Powder for Injection 1 gm | Each Pack | 5318.10 | 1213(E) | 25.03.2020 |
358 | Gemcitabine | Powder for Injection 200mg | Each Pack | 1174.50 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
359 | Gentamicin | Drops 0.3% | 1 ml | 0.91 | 1213(E) | 25.03.2020 |
360 | Gentamicin | Injection 10 mg/ml | 1 ml | 3.19 | 1213(E) | 25.03.2020 |
361 | Gentamicin | Injection 40 mg/ml | Each Pack (10 ml) | 18.01 | 1213(E) | 25.03.2020 |
362 | Gentamicin | Injection 40 mg/ml | Each Pack (2 ml) | 8.44 | 1213(E) | 25.03.2020 |
363 | Gentamicin | Injection 40 mg/ml | Each Pack (20 ml) | 27.30 | 1213(E) | 25.03.2020 |
364 | Gentamicin | Injection 40 mg/ml | Each Pack (30 ml) | 29.88 | 1213(E) | 25.03.2020 |
365 | Glimepiride | Tablet 1 mg | 1 Tablet | 3.60 | 1213(E) | 25.03.2020 |
366 | Glimepiride | Tablet 2 mg | 1 Tablet | 5.72 | 1213(E) | 25.03.2020 |
367 | Glucose | Injection 25% | 1 ml | 0.17 | 1213(E) | 25.03.2020 |
368 | Glucose | Injection 50% | 1 ml | 0.49 | 1213(E) | 25.03.2020 |
369 | Glucose | Injection 5% | 1000ml Glass | 64.38 | 1213(E) | 25.03.2020 |
370 | Glucose | Injection 5% | 1000ml Non- Glass | 51.97 | 1213(E) | 25.03.2020 |
371 | Glucose | Injection 5% | 100ml Glass | 18.07 | 1213(E) | 25.03.2020 |
372 | Glucose | Injection 5% | 100ml Non- Glass | 16.36 | 1213(E) | 25.03.2020 |
373 | Glucose | Injection 5% | 250ml Glass | 24.97 | 1213(E) | 25.03.2020 |
374 | Glucose | Injection 5% | 250ml Non- Glass | 22.56 | 1213(E) | 25.03.2020 |
375 | Glucose | Injection 5% | 500ml Glass | 35.44 | 1213(E) | 25.03.2020 |
376 | Glucose | Injection 5% | 500ml Non- Glass | 30.58 | 1213(E) | 25.03.2020 |
377 | Glucose | Injection 10% | Each Pack (1000 ml) | 25.89 | 1213(E) | 25.03.2020 |
378 | Glucose | Injection 10% | Each Pack (500 ml) | 28.16 | 1213(E) | 25.03.2020 |
379 | Glucose (A) + Sodium Chloride (B) | Injection 5% (A) + 0.9% (B) | 1000ml Glass | 64.80 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
380 | Glucose (A) + Sodium Chloride (B) | Injection 5% (A) + 0.9% (B) | 1000ml Non- Glass | 52.36 | 1213(E) | 25.03.2020 |
381 | Glucose (A) + Sodium Chloride (B) | Injection 5% (A) + 0.9% (B) | 100ml Glass | 18.12 | 1213(E) | 25.03.2020 |
382 | Glucose (A) + Sodium Chloride (B) | Injection 5% (A) + 0.9% (B) | 100ml Non- Glass | 16.38 | 1213(E) | 25.03.2020 |
383 | Glucose (A) + Sodium Chloride (B) | Injection 5% (A) + 0.9% (B) | 250ml Glass | 25.07 | 1213(E) | 25.03.2020 |
384 | Glucose (A) + Sodium Chloride (B) | Injection 5% (A) + 0.9% (B) | 250ml Non- Glass | 22.64 | 1213(E) | 25.03.2020 |
385 | Glucose (A) + Sodium Chloride (B) | Injection 5% (A) + 0.9% (B) | 500ml Glass | 35.62 | 1213(E) | 25.03.2020 |
386 | Glucose (A) + Sodium Chloride (B) | Injection 5% (A) + 0.9% (B) | 500ml Non- Glass | 30.77 | 1213(E) | 25.03.2020 |
387 | Glutaraldehyde | Solution 2% | 1 ml | 0.06 | 1213(E) | 25.03.2020 |
388 | Glycerin | Oral Liquid | 1 ml | 0.15 | 1213(E) | 25.03.2020 |
389 | Glyceryl Trinitrate | Injection 5 mg/ml | 1 ml | 6.58 | 1213(E) | 25.03.2020 |
390 | Glyceryl Trinitrate | Sublingual Tablet 0.5 mg | 1 Tablet | 1.81 | 1213(E) | 25.03.2020 |
391 | Glycopyrrolate | Injection 0.2 mg/ml | 1 ml | 12.32 | 1213(E) | 25.03.2020 |
392 | Griseofulvin | Tablet 125mg | 1 Tablet | 0.82 | 1213(E) | 25.03.2020 |
393 | Griseofulvin | Tablet 250 mg | 1 Tablet | 1.60 | 1213(E) | 25.03.2020 |
394 | Griseofulvin | Tablet 375 mg | 1 Tablet | 4.31 | 1213(E) | 25.03.2020 |
395 | Haemodialysis fluid | As license | 1 ml | 0.04 | 1213(E) | 25.03.2020 |
396 | Haloperidol | Injection 5 mg/ml | 1 ml | 5.84 | 1213(E) | 25.03.2020 |
397 | Haloperidol | Oral Liquid 2 mg/ 5ml | 1 ml | 2.06 | 1213(E) | 25.03.2020 |
398 | Haloperidol | Tablet 1.5 mg | 1 Tablet | 1.66 | 1213(E) | 25.03.2020 |
399 | Haloperidol | Tablet 10 mg | 1 Tablet | 4.42 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
400 | Haloperidol | Tablet 20 mg | 1 Tablet | 4.94 | 1213(E) | 25.03.2020 |
401 | Haloperidol | Tablet 5 mg | 1 Tablet | 3.45 | 1213(E) | 25.03.2020 |
402 | Halothane | Inhalation | 1 ml | 5.87 | 1213(E) | 25.03.2020 |
403 | Heparin | Injection 1000 IU/ml | 1 ml | 16.35 | 1213(E) | 25.03.2020 |
404 | Heparin | Injection 5000 IU/ml | 1 ml | 40.58 | 1213(E) | 25.03.2020 |
405 | Hepatitis B immunoglobulin | Each Pack | 5521.66 | 1213(E) | 25.03.2020 | |
406 | Hepatitis B vaccine | 1 ml | 78.50 | 1213(E) | 25.03.2020 | |
407 | Homatropine | Drops 2% | 1 ml | 6.22 | 1213(E) | 25.03.2020 |
408 | Hormone releasing IUD | Contains 52 mgof Levonorgestrel | 1 IUD | 3877.55 | 1213(E) | 25.03.2020 |
409 | Human chorionic Gonadotropin | Injection 1000 IU | Each Pack | 213.04 | 1213(E) | 25.03.2020 |
410 | Human chorionic Gonadotropin | Injection 5000 IU | Each Pack | 418.37 | 1213(E) | 25.03.2020 |
411 | Human Normal Immunoglobulin | Solution for infusion 5% | 1 ml | 154.65 | 1213(E) | 25.03.2020 |
412 | Human Normal Immunoglobulin | Solution for infusion 10% | 1 ml | 209.38 | 1213(E) | 25.03.2020 |
413 | Human Normal Immunoglobulin | Solution for infusion 16.5% | 1 ml | 381.87 | 1241(E) | 03.04.2020 |
414 | Hydrochlorothiazid e | Tablet 12.5 mg | 1 Tablet | 0.99 | 1213(E) | 25.03.2020 |
415 | Hydrochlorothiazid e | Tablet 25 mg | 1 Tablet | 1.69 | 1213(E) | 25.03.2020 |
416 | Hydrochlorothiazid e | Tablet 50 mg | 1 Tablet | 0.08 | 1213(E) | 25.03.2020 |
417 | Hydrocortisone | Tablet 10 mg | 1 Tablet | 5.90 | 1213(E) | 25.03.2020 |
418 | Hydrocortisone | Tablet 5 mg | 1 Tablet | 3.04 | 1213(E) | 25.03.2020 |
419 | Hydrocortisone | Injection 100 mg | Each Pack | 39.01 | 1213(E) | 25.03.2020 |
420 | Hydrocortisone | Injection 200 mg | Each Pack | 60.14 | 1213(E) | 25.03.2020 |
421 | Hydrocortisone | Powder for Injection 100 mg | Each Pack | 39.01 | 1213(E) | 25.03.2020 |
422 | Hydrogen peroxide | Solution 6% | 1 ml | 0.04 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
423 | Hydroxychloroquin e | Tablet 200 mg | 1 Tablet | 5.94 | 1213(E) | 25.03.2020 |
424 | Hydroxychloroquin e | Tablet 400 mg | 1 Tablet | 11.97 | 1213(E) | 25.03.2020 |
425 | Hydroxypropyl methylcellulose | Injection 2% | 1 ml | 37.59 | 1213(E) | 25.03.2020 |
426 | Hydroxyurea | Capsule 500 mg | 1 Capsule | 12.85 | 1213(E) | 25.03.2020 |
427 | Hyoscine butylbromide | Injection 20 mg/ml | 1 ml | 10.46 | 1213(E) | 25.03.2020 |
428 | Hyoscine Butylbromide | Tablet 10 mg | 1 Tablet | 2.98 | 1213(E) | 25.03.2020 |
429 | Ibuprofen | Capsule 400 mg | 1 Capsule | 1.06 | 1213(E) | 25.03.2020 |
430 | Ibuprofen | Capsule 200 mg | 1 soft gelatin capsule | 2.68 | 1213(E) | 25.03.2020 |
431 | Ibuprofen | Tablet 200 mg | 1 Tablet | 0.39 | 1213(E) | 25.03.2020 |
432 | Ibuprofen | Tablet 400 mg | 1 Tablet | 0.69 | 1213(E) | 25.03.2020 |
433 | Ibuprofen | Oral Liquid 100mg/5ml | 1 ml | 0.19 | 1213(E) | 25.03.2020 |
434 | Ifosfamide | Powder for Injection 1g | Each Pack | 362.72 | 1213(E) | 25.03.2020 |
435 | Ifosfamide | Powder for Injection 2g | Each Pack | 952.09 | 1213(E) | 25.03.2020 |
436 | Imatinib | Capsule 100 mg | 1 Capsule | 77.82 | 1213(E) | 25.03.2020 |
437 | Imatinib | Capsule 400 mg | 1 Capsule | 256.04 | 1213(E) | 25.03.2020 |
438 | Imatinib | Tablet 100 mg | 1 Tablet | 79.61 | 1213(E) | 25.03.2020 |
439 | Imatinib | Tablet 400 mg | 1 Tablet | 230.47 | 1213(E) | 25.03.2020 |
440 | Insulin (Soluble) | Injection 40 IU/ml | 1 ml | 15.09 | 1213(E) | 25.03.2020 |
441 | Intermediate Acting (NPH) Insulin | Injection 40 IU/ml | 1 ml | 15.09 | 1213(E) | 25.03.2020 |
442 | Iohexol | Injection 300mgiodine/ml | 1 ml | 16.67 | 1213(E) | 25.03.2020 |
443 | Ipratropium | Inhalation (MDI/DPI) 20 mcg/dose | 1 Dose | 0.61 | 1213(E) | 25.03.2020 |
444 | Ipratropium | Respirator solution for use in Nebulizer 250 mcg/ml | 1 ml | 2.54 | 1213(E) | 25.03.2020 |
445 | Iron sucrose | Injection 20 mg/ml | 1 ml | 53.88 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
446 | Isoflurane | Inhalation | 1 ml | 10.48 | 1213(E) | 25.03.2020 |
447 | Isoniazid | Tablet 100mg | 1 Tablet | 0.68 | 1213(E) | 25.03.2020 |
448 | Isoniazid | Tablet 300mg | 1 Tablet | 1.20 | 1213(E) | 25.03.2020 |
449 | Isosorbide 5 Mononitrate | Tablet 20 mg | 1 Tablet | 3.29 | 1213(E) | 25.03.2020 |
450 | Isosorbide dinitrate | Tablet 10 mg | 1 Tablet | 0.73 | 1213(E) | 25.03.2020 |
451 | Isosorbide dinitrate | Tablet 5 mg | 1 Tablet | 0.75 | 1213(E) | 25.03.2020 |
452 | Isosorbide-5- mononitrate | SR Capsule 30 mg | 1 Capsule | 3.51 | 1213(E) | 25.03.2020 |
453 | Isosorbide-5- mononitrate | SR Capsule 60 mg | 1 Capsule | 3.49 | 1213(E) | 25.03.2020 |
454 | Isosorbide-5- mononitrate | SR Tablet 30 mg | 1 Tablet | 4.91 | 1213(E) | 25.03.2020 |
455 | Isosorbide-5- mononitrate | SR Tablet 60 mg | 1 Tablet | 6.40 | 1213(E) | 25.03.2020 |
456 | Isosorbide-5- mononitrate | Tablet 10 mg | 1 Tablet | 1.97 | 1213(E) | 25.03.2020 |
457 | Ispaghula | Granules/ Husk/ Powder | 1 gm | 0.77 | 1213(E) | 25.03.2020 |
458 | IUD containing Copper | As licensed | 1 IUD | 288.19 | 1213(E) | 25.03.2020 |
459 | Japanese Encephalitis Vaccine | 4mcg to 6mcg | Each Pack | 699.24 | 1213(E) | 25.03.2020 |
460 | Japanese Encephalitis Vaccine | up to 3mcg | Each Pack | 532.72 | 1213(E) | 25.03.2020 |
461 | Kanamycin | Powder for Injection 1 gm | Each Pack | 39.20 | 1213(E) | 25.03.2020 |
462 | Kanamycin | Powder for Injection 500 mg | Each Pack | 21.38 | 1213(E) | 25.03.2020 |
463 | Kanamycin | Powder for Injection 750 mg | Each Pack | 36.53 | 1213(E) | 25.03.2020 |
464 | Ketamine | Injection 10 mg/ml | 1 ml | 10.62 | 1213(E) | 25.03.2020 |
465 | Ketamine | Injection 50 mg/ml | 1 ml | 10.48 | 1213(E) | 25.03.2020 |
466 | Labetalol | Injection 5 mg/ml | 1 ml | 50.81 | 1213(E) | 25.03.2020 |
467 | Lactulose | Oral Liquid 10 g/15 ml | 1 ml | 1.10 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
468 | Lamivudine (A) + Nevirapine (B) + Stavudine (C) | Tablet 150 mg(A) + 200 mg(B) + 30 mg(C) | 1 Tablet | 15.64 | 1213(E) | 25.03.2020 |
469 | Lamivudine (A) + Zidovudine (B) | Tablet 150 mg(A) + 300 mg(B) | 1 Tablet | 20.11 | 1213(E) | 25.03.2020 |
470 | Lamivudine (A)+ Nevirapine (B) + Stavudine (C) | Dispersible Tablet 30 mg(A) + 50 mg(B) + 6 mg(C) | 1 Tablet | 4.96 | 1213(E) | 25.03.2020 |
471 | L-Asparaginase | Powder for Injection 10000 KU | Each Pack | 1609.22 | 1213(E) | 25.03.2020 |
472 | L-Asparaginase | Powder for Injection 5000KU | Each Pack | 1038.73 | 1213(E) | 25.03.2020 |
473 | Leflunomide | Tablet 10 mg | 1 Tablet | 10.03 | 1213(E) | 25.03.2020 |
474 | Leflunomide | Tablet 20 mg | 1 Tablet | 19.58 | 1213(E) | 25.03.2020 |
475 | Letrozole | Tablet 2.5 mg | 1 Tablet | 40.87 | 1213(E) | 25.03.2020 |
476 | Levetiracetam | Injection 100 mg/ml | 1 ml | 21.87 | 1213(E) | 25.03.2020 |
477 | Levetiracetam | ER Tablet 750 mg | 1 Tablet | 17.43 | 1213(E) | 25.03.2020 |
478 | Levetiracetam | Tablet 250 mg | 1 Tablet | 5.86 | 1213(E) | 25.03.2020 |
479 | Levetiracetam | Tablet 500 mg | 1 Tablet | 11.85 | 1213(E) | 25.03.2020 |
480 | Levetiracetam | Tablet 750 mg | 1 Tablet | 18.23 | 1213(E) | 25.03.2020 |
481 | Levetiracetam | Oral Liquid 100 mg/ml | 1 ml | 3.66 | 1213(E) | 25.03.2020 |
482 | Levodopa (A) + Carbidopa (B) | CR Tablet 100 mg(A) + 25 mg(B) | 1 Tablet | 3.34 | 1213(E) | 25.03.2020 |
483 | Levodopa (A) + Carbidopa (B) | Tablet 100 mg(A) + 10 mg(B) | 1 Tablet | 1.56 | 1213(E) | 25.03.2020 |
484 | Levodopa (A) + Carbidopa (B) | Tablet 100 mg(A) + 25 mg(B) | 1 Tablet | 2.26 | 1213(E) | 25.03.2020 |
485 | Levodopa (A) + Carbidopa (B) | Tablet 250 mg(A) + 25 mg(B) | 1 Tablet | 3.75 | 1213(E) | 25.03.2020 |
486 | Levodopa (A) + Carbidopa (B) | CR Tablet 200 mg(A) + 50 mg(B) | 1 Tablet | 4.12 | 1213(E) | 25.03.2020 |
487 | Levofloxacin | Tablet 250 mg | 1 Tablet | 4.42 | 1213(E) | 25.03.2020 |
488 | Levofloxacin | Tablet 750 mg | 1 Tablet | 10.96 | 1213(E) | 25.03.2020 |
489 | Levofloxacin | Tablet 500mg | 1 Tablet | 8.08 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
490 | Levonorgestrel | Tablet 0.75 mg | 1 Tablet | 23.07 | 1213(E) | 25.03.2020 |
491 | Levothyroxine | Tablet 100 mcg | 1 Tablet | 1.20 | 1213(E) | 25.03.2020 |
492 | Levothyroxine | Tablet 112mcg | 1 Tablet | 1.44 | 1213(E) | 25.03.2020 |
493 | Levothyroxine | Tablet 12.5 mcg | 1 Tablet | 1.35 | 1213(E) | 25.03.2020 |
494 | Levothyroxine | Tablet 125 mcg | 1 Tablet | 1.54 | 1213(E) | 25.03.2020 |
495 | Levothyroxine | Tablet 150 mcg | 1 Tablet | 1.55 | 1213(E) | 25.03.2020 |
496 | Levothyroxine | Tablet 25 mcg | 1 Tablet | 1.31 | 1213(E) | 25.03.2020 |
497 | Levothyroxine | Tablet 50 mcg | 1 Tablet | 0.99 | 1213(E) | 25.03.2020 |
498 | Levothyroxine | Tablet 62.5mcg | 1 Tablet | 1.41 | 1213(E) | 25.03.2020 |
499 | Levothyroxine | Tablet 75 mcg | 1 Tablet | 1.30 | 1213(E) | 25.03.2020 |
500 | Levothyroxine | Tablet 88 mcg | 1 Tablet | 1.54 | 1213(E) | 25.03.2020 |
501 | Lignocaine | Injection 2% | 1 ml | 0.99 | 1213(E) | 25.03.2020 |
502 | Lignocaine | Injection 2%(Preservative free for IV use) | 1 ml | 0.98 | 1213(E) | 25.03.2020 |
503 | Lignocaine | Injection 1% | Each Pack | 7.96 | 1213(E) | 25.03.2020 |
504 | Lignocaine | Topical Forms 2-5% | 1 gm or 1 ml | 1.08 | 1213(E) | 25.03.2020 |
505 | Lignocaine | Injection 5% with 7.5% Glucose | 1 ml | 3.69 | 1213(E) | 25.03.2020 |
506 | Lignocaine (A) + Adrenaline (B) | Injection 1% (A) + 1:200000 (5 mcg/ml) (B) | 1 ml | 0.45 | 1213(E) | 25.03.2020 |
507 | Lignocaine (A) + Adrenaline (B) | Injection 2% (A) + 1:200000 (5mcg/ml) (B) | 1 ml | 0.92 | 1213(E) | 25.03.2020 |
508 | Linezolid | Tablet 600 mg | 1 Tablet | 33.12 | 1213(E) | 25.03.2020 |
509 | Lithium | Tablet 300 mg | 1 Tablet | 1.47 | 1213(E) | 25.03.2020 |
510 | Loperamide | Capsule 2 mg | 1 Capsule | 3.59 | 1213(E) | 25.03.2020 |
511 | Loperamide | Tablet 2 mg | 1 Tablet | 1.98 | 1213(E) | 25.03.2020 |
512 | Lopinavir (A) + Ritonavir (B) | Tablet 100 mg(A) + 25 mg(B) | 1 Tablet | 23.57 | 1213(E) | 25.03.2020 |
513 | Lopinavir (A) + Ritonavir (B) | Tablet 200 mg(A) + 50 mg(B) | 1 Tablet | 45.67 | 1213(E) | 25.03.2020 |
514 | Lorazepam | injection 2 mg/ml | 1 ml | 7.79 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
515 | Lorazepam | Tablet 1 mg | 1 Tablet | 2.07 | 1213(E) | 25.03.2020 |
516 | Lorazepam | Tablet 2 mg | 1 Tablet | 2.52 | 1213(E) | 25.03.2020 |
517 | Magnesium Sulphate | Injection 500 mg/ml | 1 ml | 4.79 | 1213(E) | 25.03.2020 |
518 | Mannitol | Injection 10% | 1 ml | 0.16 | 1213(E) | 25.03.2020 |
519 | Mannitol | Injection 20% | 1 ml | 0.30 | 1213(E) | 25.03.2020 |
520 | Measles Rubbela Vaccine | Each Pack (0.5ml) | 88.62 | 1213(E) | 25.03.2020 | |
521 | Measles vaccine | Vaccine | Each Pack (0.5ml) | 51.11 | 1213(E) | 25.03.2020 |
522 | Mebendazole | Oral Liquid 100 mg/5ml | 1 ml | 0.77 | 1213(E) | 25.03.2020 |
523 | Mebendazole | Tablet 100 mg | 1 Tablet | 2.94 | 1213(E) | 25.03.2020 |
524 | Medroxyprogester oneacetate | Tablet 10 mg | 1 Tablet | 5.40 | 1213(E) | 25.03.2020 |
525 | Mefenamic acid | Oral Liquid 100 mg/5ml | 1 ml | 0.52 | 1213(E) | 25.03.2020 |
526 | Mefenamic acid | Tablet 250 mg | 1 Tablet | 1.94 | 1213(E) | 25.03.2020 |
527 | Mefenamic acid | Tablet 500 mg | 1 Tablet | 2.46 | 1213(E) | 25.03.2020 |
528 | Mefloquine | Tablet 250 mg | 1 Tablet | 51.10 | 1213(E) | 25.03.2020 |
529 | Meglumine Diatrizoate | Injection 60%w/v | 1 ml | 8.28 | 1213(E) | 25.03.2020 |
530 | Meglumine Diatrizoate | Injection 76%w/v | 1 ml | 9.57 | 1213(E) | 25.03.2020 |
531 | Melphalan | Tablet 2 mg | 1 Tablet | 98.34 | 1213(E) | 25.03.2020 |
532 | Melphalan | Tablet 5 mg | 1 Tablet | 168.67 | 1213(E) | 25.03.2020 |
533 | Mesna | Injection 100 mg/ml | 1 ml | 16.81 | 1213(E) | 25.03.2020 |
534 | Metformin | Immediate Release Tablet 500 mg | 1 Tablet | 1.51 | 1213(E) | 25.03.2020 |
535 | Metformin | Controlled Release Tablet 1000 mg | 1 Tablet | 3.66 | 1213(E) | 25.03.2020 |
536 | Metformin | Controlled Release Tablet 500 mg | 1 Tablet | 1.92 | 1213(E) | 25.03.2020 |
537 | Metformin | controlled Released Tablet 750 mg | 1 Tablet | 2.40 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
538 | Metformin | Immediate Release Tablet 1000 mg | 1 Tablet | 3.61 | 1213(E) | 25.03.2020 |
539 | Metformin | Immediate Release Tablet 750 mg | 1 Tablet | 3.05 | 1213(E) | 25.03.2020 |
540 | Methotrexate | Injection 25 mg/ml | 1 ml | 48.22 | 1213(E) | 25.03.2020 |
541 | Methotrexate | Injection 50 mg/ml | 1 ml | 40.15 | 1213(E) | 25.03.2020 |
542 | Methotrexate | Tablet 10 mg | 1 Tablet | 12.17 | 1213(E) | 25.03.2020 |
543 | Methotrexate | Tablet 2.5 mg | 1 Tablet | 4.80 | 1213(E) | 25.03.2020 |
544 | Methotrexate | Tablet 7.5 mg | 1 Tablet | 11.61 | 1213(E) | 25.03.2020 |
545 | Methotrexate | Tablet 5 mg | 1 Tablet | 8.39 | 1213(E) | 25.03.2020 |
546 | Methyldopa | Tablet 250 mg | 1 Tablet | 2.45 | 1213(E) | 25.03.2020 |
547 | Methyldopa | Tablet 500 mg | 1 Tablet | 4.70 | 1213(E) | 25.03.2020 |
548 | Methylergometrine | Injection 0.2 mg/ml | 1 ml | 14.31 | 1213(E) | 25.03.2020 |
549 | Methylergometrine | Tablet 0.125 mg | 1 Tablet | 7.94 | 1213(E) | 25.03.2020 |
550 | Methylprednisolon e | Tablet 16 mg | 1 Tablet | 8.94 | 1213(E) | 25.03.2020 |
551 | Methylprednisolon e | Tablet 8 mg | 1 Tablet | 5.11 | 1213(E) | 25.03.2020 |
552 | Methylprednisolon e | Injection 40mg/ml | 1 ml | 54.10 | 1213(E) | 25.03.2020 |
553 | Methylrosanilinium chloride (Gentian Violet) | Paint 1% | 1 ml | 0.08549 | 4334(E) | 03.12.2020 |
554 | Metoclopramide | Injection 5 mg/ml (10 ml Pack) | 1 ml | 1.43 | 1213(E) | 25.03.2020 |
555 | Metoclopramide | Injection 5 mg/ml (2 ml Pack) | 1 ml | 2.34 | 1213(E) | 25.03.2020 |
556 | Metoclopramide | Oral Liquid 5 mg/5ml | 1 ml | 0.44 | 1213(E) | 25.03.2020 |
557 | Metoclopramide | Tablet 10 mg | 1 Tablet | 1.17 | 1213(E) | 25.03.2020 |
558 | Metoprolol | Capsule 25 mg | 1 Capsule | 4.24 | 1213(E) | 25.03.2020 |
559 | Metoprolol | Capsule 50 mg | 1 Capsule | 6.46 | 1213(E) | 25.03.2020 |
560 | Metoprolol | SR Tablet 25 mg | 1 Tablet | 4.04 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
561 | Metoprolol | SR Tablet 50 mg | 1 Tablet | 5.79 | 1213(E) | 25.03.2020 |
562 | Metoprolol | Tablet 25 mg | 1 Tablet | 3.12 | 1213(E) | 25.03.2020 |
563 | Metoprolol | Tablet 50 mg | 1 Tablet | 4.73 | 1213(E) | 25.03.2020 |
564 | Metronidazole | Injection 500mg/100ml | 1 ml | 0.20 | 1213(E) | 25.03.2020 |
565 | Metronidazole | Oral Liquid 200 mg/5ml | 1 ml | 0.45 | 1213(E) | 25.03.2020 |
566 | Metronidazole | Tablet 200 mg | 1 Tablet | 0.69 | 1213(E) | 25.03.2020 |
567 | Metronidazole | Tablet 400 mg | 1 Tablet | 1.28 | 1213(E) | 25.03.2020 |
568 | Midazolam | Injection 1 mg/ml | 1 ml | 5.92 | 1213(E) | 25.03.2020 |
569 | Midazolam | Injection 5 mg/ml | 1 ml | 14.55 | 1213(E) | 25.03.2020 |
570 | Midazolam | Tablet 7.5mg | 1 Tablet | 22.50 | 1213(E) | 25.03.2020 |
571 | Mifepristone | Tablet 200 mg | 1 Tablet | 322.49 | 1213(E) | 25.03.2020 |
572 | Misoprostol | Tablet 100 mcg | 1 Tablet | 8.73 | 1213(E) | 25.03.2020 |
573 | Misoprostol | Tablet 200 mcg | 1 Tablet | 16.74 | 1213(E) | 25.03.2020 |
574 | Morphine | Injection 10 mg/ml | 1 ml | 23.81 | 1213(E) | 25.03.2020 |
575 | Morphine | Injection 15 mg/ml | 1 ml | 29.71 | 1213(E) | 25.03.2020 |
576 | Morphine | SR Tablet 30 mg | 1 Tablet | 5.46 | 1213(E) | 25.03.2020 |
577 | Morphine | Tablet 10 mg | 1 Tablet | 5.34 | 1213(E) | 25.03.2020 |
578 | Moxifloxacin | Tablet 400 mg | 1 Tablet | 25.40 | 1213(E) | 25.03.2020 |
579 | Mycophenolate mofetil | Tablet 250 mg | 1 Tablet | 41.62 | 1213(E) | 25.03.2020 |
580 | Mycophenolate mofetil | Tablet 500 mg | 1 Tablet | 82.33 | 1213(E) | 25.03.2020 |
581 | N-acetylcysteine | Injection 200 mg/ml | 1 ml | 22.46 | 1213(E) | 25.03.2020 |
582 | N-acetylcysteine | Sachet 200mg | 1 gm | 9.02 | 1213(E) | 25.03.2020 |
583 | Naloxone | injection 0.4 mg/ml | 1 ml | 86.96 | 1213(E) | 25.03.2020 |
584 | Natamycin | Drops 5% | 1 ml | 22.86 | 1213(E) | 25.03.2020 |
585 | Neostigmine | injection 0.5 mg/ml | 1 ml | 4.36 | 1213(E) | 25.03.2020 |
586 | Neostigmine | Tablet 15 mg | 1 Tablet | 4.68 | 1213(E) | 25.03.2020 |
587 | Nevirapine | Oral Liquid 50 mg/5ml | 1 ml | 0.84 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
588 | Nevirapine | Tablet 200 mg | 1 Tablet | 14.35 | 1213(E) | 25.03.2020 |
589 | Nifedipine | Capsule 10 mg | 1 Capsule | 0.86 | 1213(E) | 25.03.2020 |
590 | Nifedipine | Tablet 10 mg | 1 Tablet | 1.24 | 1213(E) | 25.03.2020 |
591 | Nitrofurantoin | Oral Liquid 25 mg/5ml | 1 ml | 0.82 | 1213(E) | 25.03.2020 |
592 | Nitrofurantoin | Tablet 100 mg | 1 Tablet | 7.25 | 1213(E) | 25.03.2020 |
593 | Nitrofurantoin | Capsule 100mg | 1 Capsule | 7.87 | 1213(E) | 25.03.2020 |
594 | Nitrous Oxide | Inhalation | Cubic Meter | 234.21 | 1213(E) | 25.03.2020 |
595 | Noradrenaline | Injection 2 mg/ml | 1 ml | 25.83 | 1213(E) | 25.03.2020 |
596 | Norethisterone | Tablet 5 mg | 1 Tablet | 5.12 | 1213(E) | 25.03.2020 |
597 | Omeprazole | Capsule 10 mg | 1 Capsule | 2.12 | 1213(E) | 25.03.2020 |
598 | Omeprazole | Capsule 20 mg | 1 Capsule | 2.50 | 1213(E) | 25.03.2020 |
599 | Omeprazole | Capsule 40 mg | 1 Capsule | 4.95 | 1213(E) | 25.03.2020 |
600 | Omeprazole | Powder for oral Liquid 20 mg | 1 gm | 1.23 | 1213(E) | 25.03.2020 |
601 | Omeprazole | Tablet 10 mg | 1 Tablet | 4.44 | 1213(E) | 25.03.2020 |
602 | Omeprazole | Tablet 20 mg | 1 Tablet | 4.94 | 1213(E) | 25.03.2020 |
603 | Omeprazole | Tablet 40 mg | 1 Tablet | 8.35 | 1213(E) | 25.03.2020 |
604 | Ondansetron | Injection 2 mg/ml | 1 ml | 5.86 | 1213(E) | 25.03.2020 |
605 | Ondansetron | Oral Liquid 2 mg/5ml | 1 ml | 1.14 | 1213(E) | 25.03.2020 |
606 | Ondansetron | Tablet 4 mg | 1 Tablet | 4.72 | 1213(E) | 25.03.2020 |
607 | Ondansetron | Tablet 8 mg | 1 Tablet | 9.78 | 1213(E) | 25.03.2020 |
608 | Oral poliomyelitis vaccine | 1 ml | 102.79 | 4335(E) | 03.12.2020 | |
609 | Oral Rehydration Salts | As Licensed | 1 gm | 0.89 | 1213(E) | 25.03.2020 |
610 | Oral Rehydration Salts | As Licensed | 1 ml | 0.14 | 1213(E) | 25.03.2020 |
611 | Oxaliplatin | Injection 100mg(as licensed) | Each Pack | 4479.80 | 1213(E) | 25.03.2020 |
612 | Oxaliplatin | Injection 50mg(as licensed) | Each Pack | 2605.35 | 1213(E) | 25.03.2020 |
613 | Oxytocin | Injection 10 IU/ml | 1 ml | 39.49 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
614 | Oxytocin | Injection 5IU/ml | 1 ml | 17.69 | 1213(E) | 25.03.2020 |
615 | Paclitaxel | Injection 100 mg/16.7 ml | 1 ml | 206.14 | 1242(E) | 03.04.2020 |
616 | Paclitaxel | Injection 30 mg/ 5ml | 1 ml | 206.14 | 1242(E) | 03.04.2020 |
617 | Pantoprazole | Injection 40 mg | Each Pack | 44.63 | 1213(E) | 25.03.2020 |
618 | Para- aminosalicylic acid | Granules (As licensed) | 1 gm | 2.85 | 1213(E) | 25.03.2020 |
619 | Paracetamol | Oral Liquid 100 mg/5ml | 1 ml | 0.51 | 1213(E) | 25.03.2020 |
620 | Paracetamol | Oral Liquid 120 mg/5ml | 1 ml | 0.53 | 1213(E) | 25.03.2020 |
621 | Paracetamol | Oral Liquid 125 mg/5ml | 1 ml | 0.34 | 1213(E) | 25.03.2020 |
622 | Paracetamol | Oral Liquid 150 mg/5ml | 1 ml | 0.58 | 1213(E) | 25.03.2020 |
623 | Paracetamol | Oral Liquid 250 mg/5ml | 1 ml | 0.60 | 1213(E) | 25.03.2020 |
624 | Paracetamol | Oral Liquid 500 mg/5ml | 1 ml | 0.64 | 1213(E) | 25.03.2020 |
625 | Paracetamol | Oral Liquid 650 mg/5ml | 1 ml | 0.52 | 1213(E) | 25.03.2020 |
626 | Paracetamol | Tablet 500 mg | 1 Tablet | 0.91 | 1213(E) | 25.03.2020 |
627 | Paracetamol | Tablet 650 mg | 1 Tablet | 1.84 | 1213(E) | 25.03.2020 |
628 | Paracetamol | Injection 150 mg/ml | Each Pack ( 0.5 ml) | 3.08 | 1213(E) | 25.03.2020 |
629 | Paracetamol | Injection 150 mg/ml | Each Pack (1 ml) | 4.21 | 1213(E) | 25.03.2020 |
630 | Paracetamol | Injection 150 mg/ml | Each Pack (2 ml) | 6.46 | 1213(E) | 25.03.2020 |
631 | Paracetamol | Injection 150 mg/ml | Each Pack (3 ml) | 8.73 | 1213(E) | 25.03.2020 |
632 | Paracetamol | Injection 150 mg/ml | Each Pack (4 ml) | 10.99 | 1213(E) | 25.03.2020 |
633 | Paracetamol | Injection 150 mg/ml | Each Pack (5 ml) | 13.25 | 1213(E) | 25.03.2020 |
634 | Paracetamol | Injection 150 mg/ml | Each Pack (7 ml) | 17.77 | 1213(E) | 25.03.2020 |
635 | Paracetamol | Suppository 170 mg | Each Suppository | 7.71 | 1213(E) | 25.03.2020 |
636 | Paracetamol | Suppository 80 mg | Each Suppository | 6.52 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
637 | Paracetamol Oral Liquid | 100 mg/ml (pediatric) | 1 ml | 1.62 | 1213(E) | 25.03.2020 |
638 | Pegylated interferon alfa 2a | Injection 180mcg | Each Pack | 7932.08 | 1213(E) | 25.03.2020 |
639 | Pegylated interferon alfa 2b | Injection 100mcg | Each Pack | 15682.67 | 1213(E) | 25.03.2020 |
640 | Pegylated interferon alfa 2b | Injection 120mcg | Each Pack | 14605.00 | 1213(E) | 25.03.2020 |
641 | Pegylated interferon alfa 2b | Injection 80mcg | Each Pack | 12537.85 | 1213(E) | 25.03.2020 |
642 | Penicillamine | Capsule 250 mg | 1 Capsule | 14.90 | 1213(E) | 25.03.2020 |
643 | Permethrin | Cream 1% | 1 gm | 1.61 | 1213(E) | 25.03.2020 |
644 | Permethrin | Cream 5% | 1 gm | 1.74 | 1213(E) | 25.03.2020 |
645 | Permethrin | Gel 5% | 1 gm | 1.47 | 1213(E) | 25.03.2020 |
646 | Permethrin | Lotion 1% | 1 gm | 0.91 | 1213(E) | 25.03.2020 |
647 | Permethrin | Lotion 5% | 1 ml | 0.98 | 1213(E) | 25.03.2020 |
648 | Pheniramine | Injection 22.75 mg/ml (2ml) | 1 ml | 2.29 | 1213(E) | 25.03.2020 |
649 | Pheniramine | Injection 22.75 mg/ml(10ml) | 1 ml | 1.71 | 1213(E) | 25.03.2020 |
650 | Phenobarbitone | Injection 200 mg/ml | 1 ml | 19.21 | 1213(E) | 25.03.2020 |
651 | Phenobarbitone | Tablet 30 mg | 1 Tablet | 1.23 | 1213(E) | 25.03.2020 |
652 | Phenobarbitone | Tablet 60 mg | 1 Tablet | 1.77 | 1213(E) | 25.03.2020 |
653 | Phenobarbitone | Oral liquid 20 mg/5 ml | 1 ml | 0.44 | 1213(E) | 25.03.2020 |
654 | Phenylephrine | Drop 10% | 1 ml | 8.10 | 1213(E) | 25.03.2020 |
655 | Phenylephrine | Drops 5% | 1 ml | 3.74 | 1213(E) | 25.03.2020 |
656 | Phenytoin | Capsule 100 mg | 1 Capsule | 1.53 | 1213(E) | 25.03.2020 |
657 | Phenytoin | Capsule 300 mg | 1 Capsule | 3.82 | 1213(E) | 25.03.2020 |
658 | Phenytoin | ERCapsule 300 mg | 1 Capsule | 3.82 | 1213(E) | 25.03.2020 |
659 | Phenytoin | injection 25 mg/ml | 1 ml | 2.52 | 1213(E) | 25.03.2020 |
660 | Phenytoin | Injection 50 mg/ml | 1 ml | 5.39 | 1213(E) | 25.03.2020 |
661 | Phenytoin | Oral Liquid 125 mg/5ml | 1 ml | 0.90 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
662 | Phenytoin | Oral Liquid 30 mg/5ml | 1 ml | 0.31 | 1213(E) | 25.03.2020 |
663 | Phenytoin | ER Tablet 300 mg | 1 Tablet | 5.82 | 1213(E) | 25.03.2020 |
664 | Phenytoin | Tablet 100 mg | 1 Tablet | 1.56 | 1213(E) | 25.03.2020 |
665 | Phenytoin | Tablet 300 mg | 1 Tablet | 4.76 | 1213(E) | 25.03.2020 |
666 | Phenytoin | Tablet 50 mg | 1 Tablet | 0.74 | 1213(E) | 25.03.2020 |
667 | Phytomenadione (Vitamin K1) | Injection 10mg/ml | 1 ml | 48.00 | 1213(E) | 25.03.2020 |
668 | Phytomenadione (Vitamin K1) | Tablet 10mg | 1 Tablet | 14.56 | 1213(E) | 25.03.2020 |
669 | Pilocarpine | Drops 2% | 1 ml | 10.13 | 1213(E) | 25.03.2020 |
670 | Pilocarpine | Drops 4% | 1 ml | 11.71 | 1213(E) | 25.03.2020 |
671 | Piperacillin (A) + Tazobactam (B) | Powder for Injection 1 g (A) + 125 mg(B) | Each Pack | 88.61 | 1213(E) | 25.03.2020 |
672 | Piperacillin (A) + Tazobactam (B) | Powder for Injection 2 g (A) + 250 mg(B) | Each Pack | 209.63 | 1213(E) | 25.03.2020 |
673 | Piperacillin (A) + Tazobactam (B) | Powder for Injection 4 g (A) + 500 mg(B) | Each Pack | 440.35 | 1213(E) | 25.03.2020 |
674 | Potassium chloride | Injection 150 mg/ml | 1 ml | 2.43 | 1213(E) | 25.03.2020 |
675 | Potassium chloride | Oral Liquid 500 mg/5ml | 1 ml | 0.29 | 1213(E) | 25.03.2020 |
676 | Potassium permanganate | Crystals for topical solution | 1 gm | 0.44 | 1213(E) | 25.03.2020 |
677 | Povidone iodine | Ointment 10% | 1 gm | 5.22 | 1213(E) | 25.03.2020 |
678 | Povidone iodine | Solution 4% | 1 ml | 1.74 | 1213(E) | 25.03.2020 |
679 | Povidone iodine | Solution 7.5% | 1 ml | 0.77 | 1213(E) | 25.03.2020 |
680 | Povidone Iodine | Solution 10% | 1 ml | 0.93 | 1213(E) | 25.03.2020 |
681 | Povidone Iodine | Solution 5% | 1 ml | 0.39 | 1213(E) | 25.03.2020 |
682 | Pralidoxime chloride (2-PAM) | Injection 25 mg/ml | 1 ml | 3.74 | 1213(E) | 25.03.2020 |
683 | Praziquantel | Tablet 600 mg | 1 tablet | 34.82 | 3977(E) | 03.11.2020 |
684 | Prednisolone | Drops 1% | 1 ml | 5.04 | 1213(E) | 25.03.2020 |
685 | Prednisolone | Injection 20 mg/2ml | 1 ml | 3.59 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
686 | Prednisolone | Oral Liquid 15 mg/ 5ml | 1 ml | 0.75 | 1213(E) | 25.03.2020 |
687 | Prednisolone | Oral Liquid 5 mg/ 5ml | 1 ml | 0.43 | 1213(E) | 25.03.2020 |
688 | Prednisolone | Tablet 10 mg | 1 Tablet | 0.98 | 1213(E) | 25.03.2020 |
689 | Prednisolone | Tablet 20 mg | 1 Tablet | 1.96 | 1213(E) | 25.03.2020 |
690 | Prednisolone | Tablet 40 mg | 1 Tablet | 2.82 | 1213(E) | 25.03.2020 |
691 | Prednisolone | Tablet 5 mg | 1 Tablet | 0.56 | 1213(E) | 25.03.2020 |
692 | Premix Insulin 30:70 Injection (Regular:NPH) | Injection 40 IU /ml | 1 ml | 15.09 | 1213(E) | 25.03.2020 |
693 | Prilocaine (A) + Lignocaine (B) | Cream 2.5% (A) + 2.5% (B ) | 1 gm | 20.50 | 1213(E) | 25.03.2020 |
694 | Primaquine | Tablet 15 mg | 1 Tablet | 4.58 | 1213(E) | 25.03.2020 |
695 | Primaquine | Tablet 2.5 mg | 1 Tablet | 1.56 | 1213(E) | 25.03.2020 |
696 | Primaquine | Tablet 7.5 mg | 1 Tablet | 2.12 | 1213(E) | 25.03.2020 |
697 | Procarbazine | Capsule 50 mg | 1 Capsule | 34.65 | 1213(E) | 25.03.2020 |
698 | Procarbazine | Tablet 50 mg | 1 Tablet | 47.22 | 1213(E) | 25.03.2020 |
699 | Proparacaine | Drops 0.5% | 1 ml | 9.99 | 1213(E) | 25.03.2020 |
700 | Propofol | Injection 10 mg/ml | 1 ml | 7.24 | 1213(E) | 25.03.2020 |
701 | Propranolol | Capsule 40 mg | 1 Capsule | 3.81 | 1213(E) | 25.03.2020 |
702 | Propranolol | Capsule 80 mg | 1 Capsule | 5.79 | 1213(E) | 25.03.2020 |
703 | Propranolol | Tablet 10 mg | 1 Tablet | 1.17 | 1213(E) | 25.03.2020 |
704 | Propranolol | Tablet 40 mg | 1 Tablet | 2.76 | 1213(E) | 25.03.2020 |
705 | Propranolol | Tablet 80 mg | 1 Tablet | 5.01 | 1213(E) | 25.03.2020 |
706 | Protamine | Injection 10 mg/ml | 1 ml | 9.27 | 1213(E) | 25.03.2020 |
707 | Pyrazinamide | Oral Liquid 250 mg/5ml | 1 ml | 0.61 | 1213(E) | 25.03.2020 |
708 | Pyrazinamide | Tablet 1000 mg | 1 Tablet | 9.45 | 1213(E) | 25.03.2020 |
709 | Pyrazinamide | Tablet 1500 mg | 1 Tablet | 10.47 | 1213(E) | 25.03.2020 |
710 | Pyrazinamide | Tablet 500 mg | 1 Tablet | 4.24 | 1213(E) | 25.03.2020 |
711 | Pyrazinamide | Tablet 750 mg | 1 Tablet | 6.45 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
712 | Pyridoxine | Tablet 100 mg | 1 Tablet | 5.60 | 1213(E) | 25.03.2020 |
713 | Pyridoxine | Tablet 10mg | 1 Tablet | 0.11 | 1213(E) | 25.03.2020 |
714 | Quinine | Injection 300 mg/ml | 1 ml | 10.19 | 1213(E) | 25.03.2020 |
715 | Quinine | Tablet 300 mg | 1 Tablet | 5.74 | 1213(E) | 25.03.2020 |
716 | Rabies Vaccine | Each Pack | 342.55 | 1213(E) | 25.03.2020 | |
717 | Raltegravir | Tablet 400 mg | 1 Tablet | 156.88 | 1213(E) | 25.03.2020 |
718 | Ramipril | Capsule 2.5 mg | 1 Capsule | 4.75 | 1213(E) | 25.03.2020 |
719 | Ramipril | Capsule 5 mg | 1 Capsule | 7.41 | 1213(E) | 25.03.2020 |
720 | Ramipril | Tablet 2.5 mg | 1 Tablet | 4.99 | 1213(E) | 25.03.2020 |
721 | Ramipril | Tablet 5 mg | 1 Tablet | 7.85 | 1213(E) | 25.03.2020 |
722 | Ranitidine | Oral Liquid 75 mg/5ml | 1 ml | 0.72 | 1213(E) | 25.03.2020 |
723 | Ranitidine | Tablet 150 mg | 1 Tablet | 0.73 | 1213(E) | 25.03.2020 |
724 | Ranitidine | Injection 25mg/ml | 1 ml | 1.62 | 1213(E) | 25.03.2020 |
725 | Ribavirin | Capsule 200 mg | 1 Capsule | 83.85 | 1213(E) | 25.03.2020 |
726 | Rifabutin | Capsule 150mg | 1 Capsule | 39.76 | 1213(E) | 25.03.2020 |
727 | Rifabutin | Tablet 150mg | 1 Tablet | 37.13 | 1213(E) | 25.03.2020 |
728 | Rifampicin | Capsule 150 mg | 1 Capsule | 2.01 | 1213(E) | 25.03.2020 |
729 | Rifampicin | Capsule 300 mg | 1 Capsule | 3.81 | 1213(E) | 25.03.2020 |
730 | Rifampicin | Capsule 450 mg | 1 Capsule | 4.95 | 1213(E) | 25.03.2020 |
731 | Rifampicin | Capsule 600 mg | 1 Capsule | 11.62 | 1213(E) | 25.03.2020 |
732 | Rifampicin | Oral Liquid 100 mg/5ml | 1 ml | 0.39 | 1213(E) | 25.03.2020 |
733 | Rifampicin | Tablet 150 mg | 1 Tablet | 1.62 | 1213(E) | 25.03.2020 |
734 | Rifampicin | Tablet 300 mg | 1 Tablet | 2.94 | 1213(E) | 25.03.2020 |
735 | Ringer Lactate | Injection 1000ml | Each Pack | 79.96 | 1213(E) | 25.03.2020 |
736 | Ringer Lactate | Injection 100ml | Each Pack | 20.94 | 1213(E) | 25.03.2020 |
737 | Ringer Lactate | Injection 250ml | Each Pack | 35.70 | 1213(E) | 25.03.2020 |
738 | Ringer Lactate | Injection 500ml | Each Pack | 45.49 | 1213(E) | 25.03.2020 |
739 | Risperidone | Oral Liquid 1 mg/ml | 1 ml | 1.94 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
740 | Risperidone | Tablet 1 mg | 1 Tablet | 3.09 | 1213(E) | 25.03.2020 |
741 | Risperidone | Tablet 2 mg | 1 Tablet | 4.94 | 1213(E) | 25.03.2020 |
742 | Risperidone | Tablet 4 mg | 1 Tablet | 10.02 | 1213(E) | 25.03.2020 |
743 | Ritonavir | Capsule 100 mg | 1 Capsule | 28.29 | 1213(E) | 25.03.2020 |
744 | Ritonavir | Tablet 100 mg | 1 Tablet | 29.10 | 1213(E) | 25.03.2020 |
745 | Rituximab | Injection 10 mg/ml | 1 ml | 760.32 | 1213(E) | 25.03.2020 |
746 | Salbutamol | Capsule 4 mg | 1 Capsule | 0.60 | 1213(E) | 25.03.2020 |
747 | Salbutamol | Inhalation (MDI/DPI) 100 mcg/dose | 1 Dose | 0.40 | 1213(E) | 25.03.2020 |
748 | Salbutamol | Oral Liquid 2 mg/5ml | 1 ml | 0.15 | 1213(E) | 25.03.2020 |
749 | Salbutamol | Respirator solution for use in Nebulizer 5 mg/ml | 1 ml | 0.70 | 1213(E) | 25.03.2020 |
750 | Salbutamol | Tablet 2 mg | 1 Tablet | 0.16 | 1213(E) | 25.03.2020 |
751 | Salbutamol | Tablet 4 mg | 1 Tablet | 0.18 | 1213(E) | 25.03.2020 |
752 | Salicylic acid | Ointment 6% | 1 gm | 1.80 | 1213(E) | 25.03.2020 |
753 | Sevoflurane | Inhalation | 1 ml | 29.98 | 1213(E) | 25.03.2020 |
754 | Silver Sulphadiazine | Cream 1% | 1 gm | 0.51 | 1213(E) | 25.03.2020 |
755 | Snake venom antiserum- Lyophilized polyvalent | Powder for Injection | 10 ml Pack | 558.57 | 1213(E) | 25.03.2020 |
756 | Snake Venom Antiserum-Soluble/ Liquid Polyvalent | Injection | Each Pack (10 ML) | 433.76 | 1213(E) | 25.03.2020 |
757 | Sodium Bicarbonate | Injection 7.5% | 1 ml | 1.41 | 1213(E) | 25.03.2020 |
758 | Sodium Bicarbonate | Injection 8.4% | 1 ml | 1.29 | 1213(E) | 25.03.2020 |
759 | Sodium Chloride | Injection 0.9% | 1000ml Glass | 59.49 | 1213(E) | 25.03.2020 |
760 | Sodium Chloride | Injection 0.9% | 1000ml Non- Glass | 46.92 | 1213(E) | 25.03.2020 |
761 | Sodium Chloride | Injection 0.9% | 100ml Glass | 17.59 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
762 | Sodium Chloride | Injection 0.9% | 100ml Non- Glass | 15.84 | 1213(E) | 25.03.2020 |
763 | Sodium Chloride | Injection 0.9% | 250ml Glass | 23.73 | 1213(E) | 25.03.2020 |
764 | Sodium Chloride | Injection 0.9% | 250ml Non- Glass | 21.30 | 1213(E) | 25.03.2020 |
765 | Sodium Chloride | Injection 0.9% | 500ml Glass | 32.99 | 1213(E) | 25.03.2020 |
766 | Sodium Chloride | Injection 0.9% | 500ml Non- Glass | 28.08 | 1213(E) | 25.03.2020 |
767 | Sodium nitrite | Injection 30 mg/ml | 1 ml | 26.05 | 3977(E) | 03.11.2020 |
768 | Sodium Nitroprusside | Injection 10 mg/ml | 1 ml | 25.88 | 1213(E) | 25.03.2020 |
769 | Sodium Valproate | Injection 100 mg/ml | 1 ml | 5.78 | 1213(E) | 25.03.2020 |
770 | Sodium Valproate | Oral Liquid 200 mg/5ml | 1 ml | 0.58 | 1213(E) | 25.03.2020 |
771 | Sodium Valproate | CR Tablets 300mg | 1 Tablet | 6.31 | 1213(E) | 25.03.2020 |
772 | Sodium Valproate | CR Tablets 500mg | 1 Tablet | 9.77 | 1213(E) | 25.03.2020 |
773 | Sodium Valproate | Tablet 200 mg | 1 Tablet | 3.11 | 1213(E) | 25.03.2020 |
774 | Sodium Valproate | Tablet 300 mg | 1 Tablet | 3.98 | 1213(E) | 25.03.2020 |
775 | Sodium Valproate | Tablet 500 mg | 1 Tablet | 6.96 | 1213(E) | 25.03.2020 |
776 | Sofosbuvir | Tablet 400 mg | 1 Tablet | 669.09 | 1213(E) | 25.03.2020 |
777 | Somatostatin | Powder for Injection 3 mg | Each pack | 1588.65 | 1213(E) | 25.03.2020 |
778 | Spironolactone | Tablet 25 mg | 1 Tablet | 1.92 | 1213(E) | 25.03.2020 |
779 | Spironolactone | Tablet 50 mg | 1 Tablet | 3.81 | 1213(E) | 25.03.2020 |
780 | Stavudine (A) + Lamivudine (B) | Tablet 30 mg(A) +150 mg(B) | 1 Tablet | 9.57 | 1213(E) | 25.03.2020 |
781 | Streptokinase | Injection 15,00,000 IU | Each Pack | 1794.35 | 1213(E) | 25.03.2020 |
782 | Streptokinase | Injection 7,50,000 IU | Each Pack | 1262.01 | 1213(E) | 25.03.2020 |
783 | Streptomycin | Powder for Injection 750 mg | Each Pack | 8.80 | 1213(E) | 25.03.2020 |
784 | Streptomycin | Powder for Injection 1 gm | Each Pack | 10.46 | 1213(E) | 25.03.2020 |
785 | Succinyl Choline | Injection 50 mg/ml | 1 ml | 4.85 | 1213(E) | 25.03.2020 |
786 | Sucralfate | Oral Liquid 1 g | 1 ml | 0.70 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
787 | Sulfasalazine | Tablet 500 mg | 1 Tablet | 3.99 | 1213(E) | 25.03.2020 |
788 | Sumatriptan | Tablet 25mg | 1 Tablet | 33.37 | 1213(E) | 25.03.2020 |
789 | Sumatriptan | Tablet 50mg | 1 Tablet | 51.66 | 1213(E) | 25.03.2020 |
790 | Surfactant | Suspension for intratracheal instillation (As liensed) | Per mg of Phospholipids in the pack | 67.05 | 1213(E) | 25.03.2020 |
791 | Tacrolimus | Capsule 0.5 mg | 1 Capsule | 22.17 | 1213(E) | 25.03.2020 |
792 | Tacrolimus | Capsule 1 mg | 1 Capsule | 39.16 | 1213(E) | 25.03.2020 |
793 | Tacrolimus | Capsule 2 mg | 1 Capsule | 76.71 | 1213(E) | 25.03.2020 |
794 | Tacrolimus | Tablet 0.5 mg | 1 Tablet | 18.78 | 3976(E) | 03.11.2020 |
795 | Tacrolimus | Tablet 1 mg | 1 Tablet | 34.49 | 3976(E) | 03.11.2020 |
796 | Tacrolimus | Tablet 2 mg | 1 Tablet | 68.13 | 3976(E) | 03.11.2020 |
797 | Tamoxifen | Tablet 10 mg | 1 Tablet | 2.58 | 1213(E) | 25.03.2020 |
798 | Tamoxifen | Tablet 20 mg | 1 Tablet | 2.92 | 1213(E) | 25.03.2020 |
799 | TD Vaccine | Each dose of 0.5ml contains: Diphtheria Toxoid ≤5Lf (≥ 2IU) Tetanus Toxoid ≥ 5Lf (≥ 40IU) | Each 0.5ml Pack | 18.79 | 3976(E) | 03.11.2020 |
800 |
TD Vaccine | Each dose of 0.5ml contains: Diphtheria Toxoid ≤5Lf (≥ 2IU) Tetanus Toxoid ≥ 5Lf (≥ 40IU) | Each 5ml Pack | 176.53 | 3976(E) | 03.11.2020 |
801 |
TD Vaccine | Each dose of 0.5ml contains: Diphtheria Toxoid ≤25Lf (≥ 30IU) Tetanus Toxoid ≥ 5Lf (≥ 40IU) | Each 0.5ml Pack | 16.11 | 3976(E) | 03.11.2020 |
802 | Telmisartan | Tablet 20 mg | 1 Tablet | 3.66 | 1213(E) | 25.03.2020 |
803 | Telmisartan | Tablet 40 mg | 1 Tablet | 6.61 | 1213(E) | 25.03.2020 |
804 | Telmisartan | Tablet 80 mg | 1 Tablet | 10.07 | 1213(E) | 25.03.2020 |
805 | Temozolomide | Capsule 100 mg | 1 Capsule | 2088.67 | 1213(E) | 25.03.2020 |
806 | Temozolomide | Capsule 20 mg | 1 Capsule | 597.87 | 1213(E) | 25.03.2020 |
807 | Temozolomide | Capsule 250 mg | 1 Capsule | 4697.81 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
808 | Temozolomide | Tablet 100 mg | 1 Tablet | 1550.39 | 1213(E) | 25.03.2020 |
809 | Temozolomide | Tablet 20 mg | 1 Tablet | 375.62 | 1213(E) | 25.03.2020 |
810 | Temozolomide | Tablet 250 mg | 1 Tablet | 3837.37 | 1213(E) | 25.03.2020 |
811 | Tenofovir | Tablet 300 mg | 1 Tablet | 47.30 | 1213(E) | 25.03.2020 |
812 | Tenofovir (A) + Lamivudine (B) | Tablet 300 mg(A) + 300 mg(B) | 1 Tablet | 45.00 | 1213(E) | 25.03.2020 |
813 | Tenofovir (A) + Lamivudine (B) + Efavirenz (C) | Tablet 300 mg(A) + 300 mg(B) + 600 mg(C) | 1 Tablet | 103.32 | 1213(E) | 25.03.2020 |
814 | Tetanus Toxoid | Injection | Each Pack (0.5ml) | 10.87 | 1213(E) | 25.03.2020 |
815 | Tetanus Toxoid | Injection | Each Pack (5 ml) | 23.50 | 1213(E) | 25.03.2020 |
816 | Thalidomide | Capsule 100 mg | 1 Capsule | 61.25 | 1213(E) | 25.03.2020 |
817 | Thalidomide | Capsule 50 mg | 1 Capsule | 35.38 | 1213(E) | 25.03.2020 |
818 | Thiamine | Injection 100 mg/ml | 1 ml | 24.86 | 1213(E) | 25.03.2020 |
819 | Thiamine | Tablet 100 mg | 1 Tablet | 3.76 | 1213(E) | 25.03.2020 |
820 | Thiopentone | Powder for Injection 0.5 gm | Each Pack | 40.83 | 1213(E) | 25.03.2020 |
821 | Thiopentone | Powder for Injection 1 gm | Each Pack | 49.54 | 1213(E) | 25.03.2020 |
822 | Timolol | Drops 0.25% | 1 ml | 5.18 | 1213(E) | 25.03.2020 |
823 | Timolol | Drops 0.5% | 1 ml | 11.95 | 1213(E) | 25.03.2020 |
824 | Tiotropium | Inhalation (MDI) 9 mcg/dose | Per Metered Dose | 2.41 | 1213(E) | 25.03.2020 |
825 | Tiotropium | Inhalation (DPI) 18 mcg/dose | Per Dose | 9.31 | 1213(E) | 25.03.2020 |
826 | Tramadol | Capsule 50 mg | 1 Capsule | 4.52 | 1213(E) | 25.03.2020 |
827 | Tramadol | Injection 50 mg/ml (20 ml Pack) | 1 ml | 1.25 | 1213(E) | 25.03.2020 |
828 | Tramadol | Injection 50 mg/ml (upto 2 ml Pack) | 1 ml | 10.50 | 1213(E) | 25.03.2020 |
829 | Tramadol | Tablet 100 mg | 1 Tablet | 19.72 | 1213(E) | 25.03.2020 |
830 | Tramadol | Tablet 50 mg | 1 Tablet | 8.08 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
831 | Tramadol | Capsule 100 mg | 1 Capsule | 9.62 | 1213(E) | 25.03.2020 |
832 | Tranexamic acid | Injection 100 mg/ml | 1 ml | 14.98 | 1213(E) | 25.03.2020 |
833 | Tranexamic acid | Tablet 500 mg | 1 Tablet | 17.41 | 1213(E) | 25.03.2020 |
834 | Trastuzumab | Injection 440 mg/50 ml | Each Pack | 60298.66 | 1213(E) | 25.03.2020 |
835 | Trihexyphenidyl | Tablet 2 mg | 1 Tablet | 1.22 | 1213(E) | 25.03.2020 |
836 | Tropicamide | Eye Drop 1% | 1 ml | 10.08 | 1213(E) | 25.03.2020 |
837 | Vancomycin | Powder for Injection 1 gm | Each Pack | 477.07 | 1213(E) | 25.03.2020 |
838 | Vancomycin | Powder for Injection 250 mg | Each Pack | 222.28 | 1213(E) | 25.03.2020 |
839 | Vancomycin | Powder for Injection 500 mg | Each Pack | 286.94 | 1213(E) | 25.03.2020 |
840 | Vecuronium | Powder for Injection 10 mg | Each Pack | 189.53 | 1213(E) | 25.03.2020 |
841 | Vecuronium | Powder for Injection 4 mg | Each Pack | 91.47 | 1213(E) | 25.03.2020 |
842 | Verapamil | Injection 2.5 mg/ml | 1 ml | 1.17 | 1213(E) | 25.03.2020 |
843 | Verapamil | Tablet 40 mg | 1 Tablet | 0.74 | 1213(E) | 25.03.2020 |
844 | Verapamil | Tablet 80 mg | 1 Tablet | 1.40 | 1213(E) | 25.03.2020 |
845 | Vinblastine | Injection 1mg/ml | 1 ml | 20.57 | 1213(E) | 25.03.2020 |
846 | Vincristine | Injection 1 mg/ml | 1 ml | 52.24 | 1213(E) | 25.03.2020 |
847 | Vitamin A | Capsule 50000 IU | 1 Capsule | 0.55 | 1213(E) | 25.03.2020 |
848 | Vitamin A | Injection 50000 IU/ml | 1 ml | 1.92 | 1213(E) | 25.03.2020 |
849 | Vitamin A | Tablet 50000 IU | 1 Tablet | 0.70 | 1213(E) | 25.03.2020 |
850 | Warfarin | Tablet 1 mg | 1 Tablet | 2.42 | 1213(E) | 25.03.2020 |
851 | Warfarin | Tablet 2 mg | 1 Tablet | 2.67 | 1213(E) | 25.03.2020 |
852 | Warfarin | Tablet 3 mg | 1 Tablet | 3.13 | 1213(E) | 25.03.2020 |
853 | Warfarin | Tablet 5 mg | 1 Tablet | 2.36 | 1213(E) | 25.03.2020 |
854 | Water for Injection | Injection | Each Pack (10 ml) | 2.33 | 1213(E) | 25.03.2020 |
855 | Water for Injection | Injection | Each Pack (5 ml) | 2.25 | 1213(E) | 25.03.2020 |
856 | White Petrolatum | Jelly 100% | 1 gm | 0.09 | 1213(E) | 25.03.2020 |
857 | Xylometazoline | Nasal Drops 0.05% | 1 ml | 3.94 | 1213(E) | 25.03.2020 |
Sl. No | Medicines | Dosage form and Strength | Unit | Ceiling price (wef 1.4.2021 with WPI @ 0.53638%) | Existing S.O. No. & Date | |
(1) | (2) | (3) | (4) | (5) | 6(a) | 6(b) |
858 | Xylometazoline | Nasal Drops 0.1% | 1 ml | 5.22 | 1213(E) | 25.03.2020 |
859 | Zidovudine | Capsule 300 mg | 1 Capsule | 2.07 | 1213(E) | 25.03.2020 |
860 | Zidovudine | Tablet 300 mg | 1 Tablet | 14.29 | 1213(E) | 25.03.2020 |
861 | Zidovudine (A) + Lamivudine (B) + Nevirapine (C) | Tablet 300 mg(A) + 150 mg(B) + 200 mg(C) | 1 Tablet | 20.20 | 1213(E) | 25.03.2020 |
862 | Zinc sulphate | Dispersible Tablet 20mg | 1 Tablet | 3.15 | 1213(E) | 25.03.2020 |
863 | Zoledronic Acid | Powder for Injection 4 mg | Each Pack | 4211.34 | 1213(E) | 25.03.2020 |
864 | Zolpidem | Capsule 5 mg | 1 Capsule | 7.37 | 1213(E) | 25.03.2020 |
865 | Zolpidem | Tablet 10 mg | 1 Tablet | 8.47 | 1213(E) | 25.03.2020 |
866 | Zolpidem | Tablet 5 mg | 1 Tablet | 5.40 | 1213(E) | 25.03.2020 |
The notification in this regard further added:
(a) The ceiling prices are applicable with effect from 01.04.2021 (ceiling prices are inclusive of Wholesale Price Index (WPI) @0.53638% for the year 2020 over 2019).
(b) In respect of formulation where pack wise ceiling price is notified, for any other pack size manufactured, the manufacturer shall approach NPPA under para 11(3) of DPCO, 2013 for specific price approval for its formulations. The formulation of Sodium Valproate includes combination of Sodium Valproate and Valproic Acid both together corresponding to Sodium Valproate of the stated strength.
(c) In respect of any other scheduled formulation, for which ceiling price is not mentioned above, the manufacturer shall approach NPPA for specific price approval for its formulations.
(d) All manufacturers of scheduled formulations, selling branded or generic or both the versions of scheduled formulations at price higher than the ceiling price (plus Goods and Services Taxes as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus Goods and Services Taxes as applicable, if any.
(e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of their formulations, on the basis of WPI @ 0.53638% for year 2020 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013.
(f) The manufacturers may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table.
(g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to NPPA in Form I as specified under Schedule-II of the DPCO, 2013.
(j) The manufacturers of above said scheduled formulations shall furnish quarterly return to NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to NPPA, in respect of discontinuation of production and / or import of scheduled formulation in FormIV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
(k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
(l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
(m) The ceiling price of Heparin Injection 1000IU/ml specified in col. (5) of Sl. No. 403 of the Table above and the ceiling price of Heparin Injection 5000IU/ml specified in col. (5) of Sl. No. 404 of the Table above would not be applicable till the time SO. 1236(E) dated 17.03.2021 is in force.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.